<SEC-DOCUMENT>0001683168-22-005083.txt : 20220722
<SEC-HEADER>0001683168-22-005083.hdr.sgml : 20220722
<ACCEPTANCE-DATETIME>20220722162843
ACCESSION NUMBER:		0001683168-22-005083
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20220722
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220722
DATE AS OF CHANGE:		20220722

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sonoma Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001367083
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680423298
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33216
		FILM NUMBER:		221100207

	BUSINESS ADDRESS:	
		STREET 1:		645 MOLLY LANE, SUITE 150
		CITY:			WOODSTOCK
		STATE:			GA
		ZIP:			30189
		BUSINESS PHONE:		800-759-9305

	MAIL ADDRESS:	
		STREET 1:		645 MOLLY LANE, SUITE 150
		CITY:			WOODSTOCK
		STATE:			GA
		ZIP:			30189

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oculus Innovative Sciences, Inc.
		DATE OF NAME CHANGE:	20060622
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>snoa_i8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:SNOA="http://sonomapharma.com/20220722">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_SNOA_sonomapharma.com_20220722 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20220722_20220722 -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001367083 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityCentralIndexKey">0001367083</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="snoa-20220722.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-22to2022-07-22">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001367083</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-22</xbrli:startDate>
        <xbrli:endDate>2022-07-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 12pt"><b>FORM&#160;<span id="xdx_904_edei--DocumentType_c20220722__20220722_zkACUvxeQwWd"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section&#160;13 OR 15(d)&#160;of
The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of
earliest event reported)&#160;<b><span id="xdx_902_edei--DocumentPeriodEndDate_c20220722__20220722_zrRF0WBVQyO6"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 22, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_90A_edei--EntityRegistrantName_c20220722__20220722_zjUxb2xes2q6" style="font-size: 12pt"><b><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityRegistrantName">SONOMA
PHARMACEUTICALS, INC.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20220722__20220722_zs5pNguj9sJ7"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityFileNumber_c20220722__20220722_zdzLRskOQ7B4"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityFileNumber">001-33216</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: top; width: 33%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20220722__20220722_z7pxbwLSGdqh"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityTaxIdentificationNumber">68-0423298</ix:nonNumeric></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or other jurisdiction</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(IRS Employer</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">of incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20220722__20220722_zQvO1ffQGfKj"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityAddressAddressLine1">645 Molly Lane</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20220722__20220722_zDsFTb1BAoub"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityAddressAddressLine2">Suite 150</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_902_edei--EntityAddressCityOrTown_c20220722__20220722_zhXc9lsVUBUe"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityAddressCityOrTown">Woodstock</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20220722__20220722_ztCIlG4ar8F2"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityAddressStateOrProvince">GA</ix:nonNumeric></span> <span id="xdx_900_edei--EntityAddressPostalZipCode_c20220722__20220722_zPA8jl7P7obe"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:EntityAddressPostalZipCode">30189</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90C_edei--CityAreaCode_c20220722__20220722_zJQ95pwi3sDa"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:CityAreaCode">(800)</ix:nonNumeric></span> <span id="xdx_909_edei--LocalPhoneNumber_c20220722__20220722_zSdxHz0S04I8"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:LocalPhoneNumber">759-9305</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Not applicable.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="text-decoration: underline">see</span>&#160;General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_908_edei--WrittenCommunications_c20220722__20220722_zMUoAVtSSokh"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_902_edei--SolicitingMaterial_c20220722__20220722_zc5v1YoABq0a"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_903_edei--PreCommencementTenderOffer_c20220722__20220722_zdjBpIGD9k8c"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 1%"><span style="font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20220722__20220722_zvAfffHHfmga"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 98%; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 34%; text-align: center"><span style="font-size: 10pt">Trading symbol(s)</span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 33%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20220722__20220722_zQxmMZX785Ge"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><span id="xdx_907_edei--TradingSymbol_c20220722__20220722_zh8GXIgcvMPi"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" name="dei:TradingSymbol">SNOA</ix:nonNumeric></span></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">The <span id="xdx_90C_edei--SecurityExchangeName_c20220722__20220722_zYZucBnfZoQ3"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&#160;12b-2&#160;of the
Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).&#160;Emerging growth company&#160;<span id="xdx_902_edei--EntityEmergingGrowthCompany_c20220722__20220722_zjzv5xrXPzAb"><ix:nonNumeric contextRef="From2022-07-22to2022-07-22" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 96px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 5.02.</b></span></td>
    <td style="text-align: left; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Appointment of New Director</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective July 22, 2022, the Company&#8217;s Board of Directors appointed
Amy Trombly, our Chief Executive Officer, to serve as a member of our Board of Directors. Ms. Trombly will not receive additional compensation
for her Board service. Ms. Trombly will serve as a Class I Director until the 2024 Annual Meeting of Stockholders.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Employment Agreements with our Chief Executive Officer and Chief
Operating Officer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective July 22, 2022, we entered into an amended and restated employment
agreement with our Chief Executive Officer, Amy Trombly. Under the amended and restated agreement, Ms. Trombly will devote substantially
all of her time, energy and skill to the performance of her duties as Chief Executive Officer for the Company. The amended and restated
agreement also provides that, in the event of termination without cause or for good reason, Ms. Trombly is entitled to a lump sum severance
equal to one time her base salary. All other material terms of the amended and restated agreement remain unchanged from her prior employment
agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3pt 0pt 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also effective July 22, 2022, we amended and restated our employment
agreement with Bruce Thornton, our Chief Operating Officer. The amended and restated agreement provides that, in the event of termination
upon change of control, Mr. Thornton is entitled to receive, in addition to the other benefits described therein, a target annual bonus
amount of 50% of his base salary. All other material terms of his amended and restated agreement remain unchanged from his prior employment
agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The foregoing descriptions of the employment agreements are not complete
and are qualified in their entirety by reference to the full text of the employment agreements, copies of which are filed herewith as
Exhibits 10.1 and 10.2 to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="text-decoration: underline">Bonus Grants</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25pt; text-align: justify">Effective July 22, 2022, the Compensation Committee of the
Board of Directors approved annual bonus awards of $162,500 for Ms. Trombly and $150,000 for Mr. Thornton.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Departure of Chief Financial Officer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As part of our on ongoing effort to cut costs
and streamline Company operations, on July 22, 2022 we commenced consolidating all of our corporate functions in the United States to
our office in Boulder, Colorado. Effective on or before December 31, 2022, we will close our office in Woodstock, Georgia. In connection
with the Woodstock office closure, Mr. Jerry Dvonch resigned as our Chief Financial Officer. Mr. Dvonch has agreed to assist us with transitioning
the Company&#8217;s operations to the Boulder office on or before December 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon Mr. Dvonch&#8217;s termination, we will pay
him severance consisting of $100,000, contingent upon his execution of a general release of claims against the Company. He will also be
entitled to up to six months&#8217; COBRA reimbursement. All outstanding time-based equity-based compensation awards will become fully
vested and all outstanding performance-based equity compensation awards will remain outstanding and will vest or be forfeited in accordance
with the terms of the applicable award agreements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="text-decoration: underline">Forward-Looking Statements Disclaimer</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This report contains forward-looking statements. Forward-looking statements
include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements
related to our future activities or future events or conditions. These statements are based on current expectations, estimates and projections
about our business based, in part, on assumptions made by management. These statements are not guarantees of future performances and involve
risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from
what is expressed or forecasted in the forward-looking statements due to numerous factors, including those risks discussed in our annual
report on Form 10-K and in other documents that we file from time to time with the SEC. Any forward-looking statements speak only as of
the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances
after the date of this report, except as required by law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
  <td style="width: 96px"><b>Item 9.01</b></td>
  <td><b>Financial Statements and Exhibits.</b></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr>
    <td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Exhibit No.</span></span></td>
    <td style="width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Description</span></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><a href="snoa_ex1001.htm">Amended and Restated Employment Agreement by and between the Company and Amy Trombly, dated July 22, 2022.</a></p></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td><a href="snoa_ex1002.htm">Amended and Restated Employment Agreement by and between the Company and Bruce Thornton, dated July 22, 2022.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Sonoma Pharmaceuticals, Inc.</span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">Registrant</td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; width: 51%"><span style="font: 10pt Times New Roman, Times, Serif">Date:July 22, 2022</span></td>
    <td style="width: 3%"><span style="font: 10pt Times New Roman, Times, Serif">By:&#160;</span></td>
    <td style="vertical-align: top; width: 46%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">/s/ Amy
    Trombly&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td colspan="2"><span style="font: 10pt Times New Roman, Times, Serif">Name: Amy Trombly<br /> Title: Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6La4bCm6XDhVxiowh3lYXpbg1I61/j+Rb2m2IIRCSc74cIUZiRUtdI8NxXuRQYtPWyiEUeEFGc0bvyNabFPws8KqtY2Vcv/7AjDyDnpmOk5O/986HtlilIJNQRmEcgZyk8Qz2WxF0ekbmois0TqsalKlgz9SyRqf4PXwo1YsMNe8+6YBsNZkUorEc5A/EMophRw/1JL5ZyPNMBKO+ArFiurddzN06amBRY+Oz7ID+O/gC4s5JIQ== -->


</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>snoa_ex1001.htm
<DESCRIPTION>AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND AMY TROMBLY, DATED JULY 22, 2022.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED EMPLOYMENT AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This AMENDED AND RESTATED
EMPLOYMENT AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;) is entered into by and between Amy Trombly (the &ldquo;<U>Executive</U>&rdquo;),
and Sonoma Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;), as of July 22, 2022 (the &ldquo;<U>Effective
Date</U>&rdquo;). This Agreement replaces that certain employment agreement dated as of July 1, 2021, and entered into by and between
the Executive and the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, prior to the
date hereof, the Executive has served as the Corporation&rsquo;s Chief Executive Officer and has continued to provide legal services through
Trombly Business Law, PC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, as of the
Effective Date, the Executive shall no longer provide legal services through Trombly Business Law, PC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Corporation
desires that the Executive continue to be employed by the Corporation as its Chief Executive Officer and to serve as a member of the Board
of Directors of the Corporation, and to carry out the duties and responsibilities described below, all on the terms and conditions set
forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Executive
is willing to accept and continue such employment on such terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the foregoing premises and the mutual covenants and promises of the parties herein, the receipt and sufficiency of which
are hereby acknowledged by each of the parties, the Corporation and the Executive hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. <U>Employment and Duties</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Position</U>. On the
terms and subject to the conditions set forth herein, the Corporation agrees to employ Executive as its Chief Executive Officer until
such time as the employment relationship ends or is terminated by either Party pursuant to <I>Section 2</I>. Executive does hereby accept
and agree to such employment, on the terms and conditions expressly set forth in this Agreement. Executive shall also serve as a member
of the Board of Directors of the Corporation (the &ldquo;<U>Board</U>&rdquo;) and may be required to serve as an officer or director of
any affiliate of the Corporation for no additional compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2 <U>Duties</U>. During
the Term of Employment (as defined in <I>Section 2</I>), Executive shall serve the Corporation as its Chief Executive Officer and as a
member of the Board of Directors of the Corporation. Executive and shall, without limitation and without limiting Executive&rsquo;s other
duties to the Corporation, and without limiting the authority of the Corporation&rsquo;s Board of Directors, be responsible for the general
supervision, direction and control of the business and affairs of the Corporation and have such other duties and responsibilities as the
Board shall designate that are consistent with Executive&rsquo;s position as Chief Executive Officer of the Corporation. Executive shall
perform all of such duties and responsibilities in accordance with the legal directives of the Board and in accordance with the practices
and policies of the Corporation as in effect from time to time throughout the Term of Employment (including, without limitation, the Corporation&rsquo;s
insider trading and ethics policies, as they may change from time to time). While employed as Chief Executive Officer of the Corporation,
Executive shall report exclusively to the Board. Throughout the Term of Employment, Executive shall not serve on the boards of directors
or advisory boards of any other entity, except for any wholly or majority owned subsidiaries of the Corporation, unless such service is
expressly approved by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3 <U>No Other Employment;
Minimum Time Commitment</U>. Throughout the Term of Employment, the Executive shall both (i) devote substantially all of the Executive&rsquo;s
business time, energy and skill to the performance of the Executive&rsquo;s duties for the Corporation, and (ii) hold no other job. The
Executive agrees that any investment or direct involvement in, or any appointment to or continuing service on the board of directors or
similar body of, any corporation or other entity, other than wholly or majority owned subsidiaries of the Corporation, must be first approved
in writing by the Corporation. The foregoing provisions of this <I>Section 1.3</I> shall not prevent the Executive from investing in non-competitive,
publicly-traded securities to the extent permitted by <I>Section 6(b)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4 <U>No Breach of Contract</U>.
Executive hereby represents to the Corporation that the execution and delivery of this Agreement by the Executive and the Corporation
and the performance by the Executive of the Executive&rsquo;s duties hereunder shall not constitute a breach of, or otherwise contravene,
the terms of any other agreement or policy to which the Executive is a party or otherwise bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5 <U>Place of Performance</U>.
The principal place of Executive&rsquo;s employment shall be the Corporation&rsquo;s offices located in Woodstock, Georgia or Boulder,
Colorado, though such principal place of employment of the Executive may be moved from time to time upon mutual agreement by the Executive
and the Corporation. The Executive agrees that the Executive will be regularly present at the Corporation&rsquo;s principal executive
offices, or such other location as the parties may designate, and that the Executive may be required to travel from time to time in the
course of performing the Executive&rsquo;s duties for the Corporation. The Corporation acknowledges that Executive&rsquo;s principal place
of residence is and will remain during the Term of Employment, Colorado.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <U>At-Will Employment, Term of Employment</U>.
The &ldquo;<U>Term of Employment</U>&rdquo; shall commence on the Effective Date, and shall continue in full force until terminated pursuant
to <I>Section 5</I>. The Parties agree that Executive&rsquo;s employment with the Corporation will be &ldquo;at-will&rdquo; employment
and may be terminated at any time with or without cause in accordance with <I>Section 5</I>. This Agreement shall govern the terms of
Executive&rsquo;s employment hereunder on and after the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <U>Compensation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Base Salary</U>. As
of the Effective Date and during the Term of Employment, the Corporation shall pay to the Executive a base salary at the rate of $27,083.33
per month ($325,000 per annum), subject to increase (but not decrease) by the Board (the &ldquo;<U>Base Salary</U>&rdquo;). For clarification,
such Base Salary includes legal work that Executive has traditionally done for the Corporation. However, it excludes work completed by
associates or paralegals at Trombly Business Law, PC which will continue to be billed in the same manner as before this Agreement was
executed. The Executive&rsquo;s Base Salary shall be paid in accordance with the Corporation&rsquo;s regular payroll practices in effect
from time to time, but no less frequently than monthly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">3.2&nbsp;<U>Annual
Bonus</U>. For each fiscal year during the Term of Employment, Executive shall be eligible to receive a target annual bonus (the &ldquo;Annual
Bonus&rdquo;) of 50% of Base Salary, up to 120% of the target Annual Bonus. The decision to provide any annual bonus and the amount and
terms of any Annual Bonus shall be in the sole and absolute discretion of the Compensation Committee of the Board. Executive must be employed
by the Corporation on the day that any Annual Bonus is paid. The Board of Directors or the Compensation Committee, as appropriate, may
in its sole discretion agree to pay a pro rata or full Annual Bonus, and if such Annual Bonus is granted, then determine the amount, form
and payment schedule.</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3 <U>Equity</U>. During
the Term of Employment, Executive shall be eligible to participate in the Corporation&rsquo;s equity-based incentive programs in effect
at the time, subject to the terms of such plans, as determined by the Board or the Compensation Committee, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4 <U>Indemnification.</U>
(a) In the event that the Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil,
criminal, administrative or investigative (a &ldquo;<U>Proceeding</U>&rdquo;), other than any Proceeding initiated by the Executive or
the Corporation related to any contest or dispute between the Executive and the Corporation or any of its affiliates with respect to this
Agreement or the Executive&rsquo;s employment hereunder, by reason of the fact that the Executive is or was a director or officer of the
Corporation, or any affiliate of the Corporation, or is or was serving at the request of the Corporation as a director, officer, member,
employee or agent of another corporation or a partnership, joint venture, trust or other enterprise, the Executive shall be indemnified
and held harmless by the Corporation to the maximum extent permitted under applicable law and the Corporation&rsquo;s articles and bylaws,
as may be amended from time to time, from and against any liabilities, costs, claims and expenses, including all costs and expenses incurred
in defense of any Proceeding (including attorneys&rsquo; fees).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) During the Term of Employment
and for a period of six (6) years thereafter, the Corporation or any successor to the Corporation shall purchase and maintain, at its
own expense, directors&rsquo; and officers&rsquo; liability insurance providing coverage to the Executive on terms that are no less favorable
than the coverage provided to other directors and similarly situated executives of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.5 <U>Clawback Provisions</U>.
Any incentive-based compensation, or any other compensation, paid to the Executive pursuant to this Agreement or any other agreement or
arrangement with the Corporation which is subject to recovery under any law, government regulation or stock exchange listing requirement,
will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange
listing requirement (or any policy adopted by the Corporation pursuant to any such law, government regulation or stock exchange listing
requirement). The Corporation will make any determination for clawback or recovery in accordance with any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4. <U>Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Health and Welfare</U>.
During the Term of Employment, Executive shall be entitled to participate in all employee pension and welfare benefit plans and programs
made available by the Corporation to the Corporation&rsquo;s senior-level employees generally, as such plans or programs may be in effect
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Reimbursement of Business
Expenses</U>. Executive is authorized to incur reasonable expenses in carrying out Executive&rsquo;s duties for the Corporation under
this Agreement and entitled to reimbursement for all such expenses Executive incurs during the Term of Employment in connection with carrying
out the Executive&rsquo;s duties for the Corporation, as approved by the Corporation&rsquo;s Chief Financial Officer and subject to the
Corporation&rsquo;s reasonable expense reimbursement policies in effect from time to time. Such expenses may include but are not limited
to travel, lodging and meals. The Corporation shall reimburse Executive to the extent required by the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Vacation and Other
Leave</U>. During the Term of Employment, Executive shall accrue and be entitled to take paid vacation of 4 weeks per annum pro-rated
in accordance with the Corporation&rsquo;s standard vacation policies in effect from time to time, including the Corporation&rsquo;s
policies regarding vacation accruals, provided however, that Executive shall be able to accrue a maximum of two times of the annual vacation
time. Executive shall also be entitled to all other holiday and leave pay generally available to all other employees of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1. <U>Termination</U>. The
Term of Employment and Executive&rsquo;s employment hereunder may be terminated by the Corporation or by Executive upon sixty (60) days&rsquo;
written notice at any time and for any reason, for or without cause, for or without good reason, or upon Death of the Executive. Upon
termination of Executive&rsquo;s employment during the Term of Employment, Executive (or the Executive&rsquo;s estate and/or beneficiaries,
as the case may be) shall be entitled to the compensation and benefits describe in this <I>Section 5 </I>and shall have no further rights
to any compensation or any other benefits from the Corporation or any of its affiliates. Notwithstanding any other provision contained
herein, all payments made in connection with Executive&rsquo;s Death shall be provided in a manner which is consistent with federal and
state law. The Corporation may deduct from all payments made hereunder, all applicable taxes and other appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2. <U>Definitions</U>. For
purposes of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<U>Accrued Amounts</U>&rdquo;
shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt">(i)&nbsp;&nbsp;&nbsp;any accrued
but unpaid Base Salary and accrued but unused vacation which shall be paid in the next regularly scheduled payroll following one (1) week
after termination; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iii) reimbursement for unreimbursed
business expenses properly incurred by the Executive, which shall be subject to and paid in accordance with the Corporation&rsquo;s expense
reimbursement policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;<U>Change in Control</U>&rdquo;
shall mean the occurrence of any of the following after the Effective Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i)&nbsp;&nbsp;one person (or
more than one person acting as a group) acquires ownership of stock of the Corporation that, together with the stock held by such person
or group, constitutes more than 50% of the total fair market value or total voting power of the stock of such corporation; provided that,
a Change in Control shall not occur if any person (or more than one person acting as a group) owns more than 50% of the total fair market
value or total voting power of the Corporation&rsquo;s stock and acquires additional stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;&nbsp;a majority
of the members of the Board are replaced during any twelve-month period by directors whose appointment or election is not endorsed by
a majority of the Board before the date of appointment or election; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iii)&nbsp;the sale of all or substantially
all of the Corporation&rsquo;s assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 63pt">Notwithstanding the foregoing,
a Change in Control shall not occur unless such transaction constitutes a change in the ownership of the Corporation, a change in effective
control of the Corporation, or a change in the ownership of a substantial portion of the Corporation&rsquo;s assets under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">For purposes of the definition of &ldquo;<U>Change
of Control</U>&rdquo;, the following definitions shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i) The term &ldquo;person&rdquo;
shall mean any individual, corporation or other entity and any group as such term is used in Section 13(d) (3) or 14(d) (2) of the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;Any person
shall be deemed to be the beneficial owner of any shares of capital stock of the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">a. which that person owns directly
whether or not of record, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">b. which that person has the right
to acquire pursuant to any agreement or understanding or upon exercise of conversion rights, warrants, or options, or otherwise, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">c. which are beneficially owned, directly
or indirectly (including shares deemed owned through application of clause (b) above, by an &ldquo;affiliate&rdquo; or &ldquo;associate&rdquo;
(as defined in the rules of the Securities and Exchange Commission under the Securities Act of 1933, as amended) of that person, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">d. which are beneficially owned, directly
or indirectly (including shares deemed owned through application of clause (b) above), by any other person with which that person or her
&ldquo;affiliate&rdquo; or &ldquo;associate&rdquo; (defined as aforesaid) has any agreement, arrangement, or understanding for the purpose
of acquiring, holding, voting or disposing of capital stock of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iii)&nbsp;&nbsp;The outstanding
shares of capital stock of the Corporation shall include shares deemed owned through application of clause (ii) (b), (c), and (d) above,
but shall not include any other shares which may be issuable pursuant to any agreement or upon exercise of conversion rights, warrants
or options, or otherwise, but which are not actually outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(c) &ldquo;<U>Cause</U>&rdquo; shall
mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i)&nbsp;&nbsp;the Executive&rsquo;s
willful failure to perform Executive&rsquo;s duties (other than any such failure resulting from incapacity due to physical or mental illness);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;the Executive&rsquo;s
willful failure to comply with any valid and legal directive of the Board communicated to Executive in writing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iii)&nbsp;&nbsp;the Executive&rsquo;s
willful engagement in dishonesty, illegal conduct or gross misconduct, which is, in each case, materially injurious to the Company Group;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iv)&nbsp;&nbsp;the Executive&rsquo;s
embezzlement, misappropriation or fraud, whether or not related to the Executive&rsquo;s employment with the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(v)&nbsp;&nbsp;the Executive&rsquo;s
conviction of or plea of guilty or&nbsp;<I>nolo contendere</I>&nbsp;to a crime that constitutes a felony (or state law equivalent) or
a crime that constitutes a misdemeanor involving moral turpitude;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(vi)&nbsp;&nbsp;the Executive&rsquo;s
violation of a material policy of the Corporation that has been provided to Executive (documents made public on the Corporation&rsquo;s
website or through filings with the U.S. Securities and Exchange Commission are deemed provide to the Executive);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(vii)&nbsp;&nbsp;the Executive&rsquo;s
willful unauthorized disclosure of Confidential Information (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt">(viii)&nbsp;&nbsp;the Executive&rsquo;s
material breach of any material obligation under this Agreement or any other written agreement between the Executive and the Corporation;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 58.5pt">(ix)&nbsp;&nbsp;any material
failure by the Executive to comply with the Corporation&rsquo;s written policies or rules, as they may be in effect from time to time
during the Employment Term, if such failure causes material, reputational or financial harm to the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">For purposes of this provision,
no act or failure to act on the part of the Executive shall be considered &ldquo;willful&rdquo; unless it is done, or omitted to be done,
by the Executive in bad faith or without reasonable belief that the Executive&rsquo;s action or omission was in the best interests of
the Corporation. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the
advice of counsel for the Corporation shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith
and in the best interests of the Corporation. In all cases the Corporation shall notify the Executive in writing of the basis for any
for Cause termination by providing a detailed description of the alleged facts and circumstances giving rise to Cause. In addition, with
respect to clauses (i), (ii), (vi), (viii) and (ix) Executive shall be given a period of at least 30 days to cure and only if Executive
fails to cure within such time period will a termination be for Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)
&ldquo;<U>Disability</U>&rdquo; shall mean the Executive&rsquo;s inability, due to physical or mental incapacity, to substantially
perform her duties and responsibilities under this Agreement, with or without reasonable accommodation, for 90 calendar days out of
any three hundred sixty-five (365) calendar day period, but only if the Executive is considered disabled within the meaning of
Treasury Regulation section 1.409A-3(i)(4). Without limiting the circumstances in which the Executive may be determined to be
disabled as defined in Treasury Regulation section 1.409A-3(i)(4), the Executive will be presumed to be disabled if determined to be
totally disabled by the Social Security Administration or if determined to be disabled in accordance with a disability insurance
program, provided the definition of disability applied under such disability insurance program complies with the requirements of
Treasury Regulation section 1.409A-3(i)(4). Any question as to the existence of the Executive&rsquo;s Disability as to which the
Executive and the Corporation cannot agree shall be determined in writing by a qualified independent physician mutually acceptable
to the Executive and the Corporation. If the Executive and the Corporation cannot agree as to a qualified independent physician,
each shall appoint such a physician and those two physicians shall select a third who shall make such determination in writing. The
determination of Disability made in writing to the Corporation and the Executive shall be final and conclusive for all purposes of
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;Good Reason&rdquo;
shall mean the occurrence of any of the following, in each case during the Employment Term without the Executive&rsquo;s written consent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i)&nbsp;&nbsp;a reduction in the Executive&rsquo;s
then current Base Salary;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii)&nbsp;&nbsp;only after
a sale of the Corporation, a relocation of the Executive&rsquo;s principal place of employment by more than 50 miles, unless the new principal
place of employment is closer to Executive&rsquo;s principal residence;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iii)&nbsp;&nbsp;the Corporation&rsquo;s
failure to obtain an agreement from any successor to the Corporation to assume and agree to perform this Agreement in the same manner
and to the same extent that the Corporation would be required to perform if no succession had taken place, except where such assumption
occurs by operation of law; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iv)&nbsp;&nbsp;a material,
adverse change in the Executive&rsquo;s title, authority, duties or responsibilities (other than temporarily while the Executive is physically
or mentally incapacitated or as required by applicable law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">The Executive cannot terminate
his employment for Good Reason unless he has provided written notice to the Corporation of the existence of the circumstances providing
grounds for termination for Good Reason within 30 business days of the initial existence of such grounds and the Corporation has had at
least 30 business days from the date on which such notice is provided to cure such circumstances. If the Executive does not terminate
his employment for Good Reason within 30 calendar days after the expiration of the cure period, then the Executive will be deemed to have
waived his right to terminate for Good Reason with respect to such grounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3. <U>Termination for Cause
or Without Good Reason</U>. In case of termination by the Corporation for Cause or by the Executive without Good Reason, Executive shall
be entitled to the Accrued Amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4. <U>Termination without
Cause or for Good Reason</U>. In case of termination without Cause by the Corporation or for Good Reason by the Executive, Executive shall
be entitled to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) </FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Accrued Amounts;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">(b) subject to the
Executive&rsquo;s compliance with&nbsp;<I>Sections 6 through 11 </I>of this Agreement and her execution of a release of claims in
favor of the Company, its affiliates and their respective officers and directors in a form attached hereto (the
&ldquo;Release&rdquo;) and such Release becoming effective within the applicable time period set forth in the Release (the
&ldquo;Release Execution Period&rdquo;), the Executive shall be entitled to receive a lump sum payment equal to one time the sum of
the Executive&rsquo;s annual Base Salary, which shall be paid within 30 days following the Release Execution Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">(c) upon determination
by the Corporation&rsquo;s Board of Directors or Compensation Committee, as appropriate, to be made in its sole discretion as to
whether to grant such bonus, a pro-rata Annual Bonus, and if such pro-rata Annual Bonus is granted, determine the amount, form and
payment schedule. For the avoidance of doubt, Executive shall not be entitled to any Annual Bonus solely for reason of termination,
unless the Board of Directors or the Compensation Committee, as appropriate, in its sole discretion awards a bonus to Executive;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">(d) If the Executive
timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985
(&ldquo;COBRA&rdquo;), the Corporation shall reimburse the Executive for the monthly COBRA premium paid by the Executive for herself
and her dependents. Such reimbursement shall be paid to the Executive on the 10th day of the month immediately following the month
in which the Executive timely remits the premium payment (&ldquo;COBRA Premium Reimbursements&rdquo;). The Executive shall be
eligible to receive such COBRA Premium Reimbursement until the earliest of: (i) the six-month anniversary of the termination; (ii)
the date the Executive is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which the Executive
becomes eligible to receive substantially similar coverage from another employer or other source. Notwithstanding the foregoing, if
the Corporation&rsquo;s making payments under this <I>Section 5.4(d)</I> would violate the nondiscrimination rules applicable to
non-grandfathered plans under the Affordable Care Act (the &ldquo;ACA&rdquo;), or result in the imposition of penalties under the
ACA and the related regulations and guidance promulgated thereunder), the parties agree to reform this <I>Section 5.4(d)</I> in a
manner as is necessary to comply with the ACA;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">(e) All outstanding
time-based equity-based compensation awards granted to the Executive during the Term of Employment shall become fully vested; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 76.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">(f) All outstanding
performance-based equity compensation awards granted to the Executive during the Term of Employment shall remain outstanding and shall
vest or be forfeited in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied.
The determination whether such performance goals are satisfied shall be in the sole discretion of the Compensation Committee or the Board,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5. <U>Termination upon Change
in Control</U>. Notwithstanding any other provision contained herein, if the Executive&rsquo;s employment hereunder is terminated or Executive&rsquo;s
responsibilities are reduced or the location of employment is moved more than 25 miles within three (3) months prior to or twelve (12)
months following a Change in Control, the Executive shall be entitled to receive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(a)  the Accrued
Amounts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(b) subject
to the Executive&rsquo;s compliance with&nbsp;<I>Sections 6 through 11</I>&nbsp;of this Agreement and execution of a Release which becomes
effective by the end of the Release Execution Period, the Executive shall be entitled to receive a lump sum payment equal to one time
the sum of the Executive&rsquo;s annual Base Salary, which shall be paid within 30 days following the Release Execution Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(c)&#8239;the
target Annual Bonus amount;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(d) If the Executive
timely and properly elects health continuation coverage under COBRA, the Corporation shall reimburse the Executive for the monthly COBRA
premium paid by the Executive for herself and her dependents. Such reimbursement shall be paid to the Executive on the 10<SUP>th</SUP>&nbsp;day
of the month immediately following the month in which the Executive timely remits the premium payment. The Executive shall be eligible
to receive such reimbursement until the earliest of: (i) the twelve-month anniversary of the termination; (ii) the date the Executive
is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which the Executive becomes eligible to receive substantially
similar coverage from another employer or other source. Notwithstanding the foregoing, if the Corporation&rsquo;s making payments under
this&nbsp;<I>Section 5.5(d)</I>&nbsp;would violate the nondiscrimination rules applicable to non-grandfathered plans under the ACA, or
result in the imposition of penalties under the ACA, the parties agree to reform this&nbsp;<I>Section 5.5(d)</I>&nbsp;in a manner as is
necessary to comply with the ACA;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) All outstanding
time-based equity-based compensation awards granted to the Executive during the Term of Employment shall become fully vested; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) All outstanding
performance-based equity compensation awards granted to the Executive during the Term of Employment shall remain outstanding and shall
vest or be forfeited in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied.
The determination whether such performance goals are satisfied shall be in the sole discretion of the Compensation Committee or the Board,
as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 <U>Release;
Exclusive Remedy</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Executive agrees that
the payments contemplated by this&nbsp;<I>Section 5</I>&nbsp;shall constitute the exclusive and sole remedy for any termination of her
employment and the Executive covenants not to assert or to pursue any other remedies, at law or in equity, with respect to any termination
of employment. The Corporation and Executive acknowledge and agree that there is no duty of the Executive to mitigate damages under this
Agreement. All amounts paid to the Executive pursuant to&nbsp;<I>Section 5</I>&nbsp;shall be paid without regard to whether the Executive
has taken or takes actions to mitigate damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) As used herein, &ldquo;<U>Release</U>&rdquo;
shall mean a written release, discharge and covenant not to sue entered into by the Executive in favor of the Corporation in the form
as in&nbsp;<U>Exhibit A</U>&nbsp;hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7. <U>Death or Disability</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Executive&rsquo;s
employment hereunder shall terminate automatically upon the Executive&rsquo;s death during the Term of Employment, and the Corporation
may terminate the Executive&rsquo;s employment on account of the Executive&rsquo;s Disability consistent with applicable law. Executive
will be eligible for any employee plans in place that cover Disability and will be eligible for any employee benefits consistent with
those plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) If the Executive&rsquo;s
employment is terminated during the Term of Employment on account of the Executive&rsquo;s death or Disability, the Executive (or the
Executive&rsquo;s estate and/or beneficiaries, as the case may be) shall be entitled to receive the Accrued Amounts. In addition, Executive&rsquo;s
spouse or partner and other dependents shall be entitled to six months of COBRA Premium Reimbursements upon timely request to the Corporation
for such benefits. All outstanding equity-based compensation awards granted to the Executive during the Term of Employment shall become
fully vested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>Equity</U>. Upon termination
under this <I>Section 5</I> for any reason, Executive&rsquo;s outstanding and vested equity awards shall remain exercisable for 18 months
following termination, subject to the provisions of the Corporation&rsquo;s equity incentive plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9 <U>Resignation From Boards
and Committees</U>. Following any termination of Executive&rsquo;s employment as Chief Executive Officer with the Corporation, Executive
agrees to resign, as of the date of such termination, from (i) each and every board of directors (or similar body, as the case may be)
of the Corporation and each of its affiliates on which Executive may then serve, including, but not limited to, the Board (and any committees
thereof), and (ii) each and every office of the Corporation and each of its affiliates that the Executive may then hold, and all positions
that he may have previously held with the Corporation and any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10 <U>Section 409A of the
Internal Revenue Code.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) This Agreement is intended
to comply with Section 409A of the Internal Revenue Code of 1986 (&ldquo;<U>Section 409A</U>&rdquo;) and shall be construed and interpreted
consistent with that intent. In the event that any payment or benefit payable under <I>Section 5</I> of this Agreement is not compliant
with Section 409A and any taxes, penalties or interest are imposed on the Executive under Section 409A as a result of such noncompliance
(the &ldquo;<U>Section 409A Penalties</U>&rdquo;), the Corporation shall put the Executive in an after-tax economic position equivalent
to the position the Executive would have been in without the imposition of such Section 409A Penalties. Executive shall notify the Corporation
in writing of any claim by the Internal Revenue Service or state tax authorities that, if successful, would require the payment of any
such Section 409A Penalties or related state tax statutes. Executive&rsquo;s right to be put in an equivalent after tax economic position
is subject to the Executive providing such notification no later than ten (10) business days after Executive is informed in writing of
such claim. If the Corporation desires to contest such claim, Executive shall (i) cooperate with the Corporation in good faith in order
to effectively contest such claim and (ii) permit the Corporation to participate in any proceedings relating to such claim. The Corporation
shall control all proceedings taken in connection with such contest; provided, however, that the Corporation shall bear and pay directly
all costs and expenses (including additional interest and penalties) incurred in connection with such contest. This section shall also
apply to any taxes, penalties, or interest imposed by any state that are calculated in a manner similar to taxes, penalties, or interest
imposed by Section 409A(a)(1)(B), including those amounts imposed by the State of Colorado tax laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) If and to the extent that
any payment or benefit under this Agreement, or any plan or arrangement of the Corporation, is determined by the Corporation to constitute
&ldquo;non-qualified deferred compensation&rdquo; subject to Section 409A and is payable to the Executive by reason of the Executive&rsquo;s
termination of employment, then (a) such payment or benefit shall be made or provided to the Executive only upon a &ldquo;separation from
service&rdquo; as defined for purposes of Section 409A under applicable regulations (a &ldquo;<U>Separation from Service</U>&rdquo;) and
(b) if the Executive is a &ldquo;specified employee&rdquo; (within the meaning of Section 409A and as determined by the Corporation),
such payment or benefit shall not be made or provided before the date that is six (6) months after the date of the Executive&rsquo;s Separation
from Service (or the Executive&rsquo;s earlier death). For the purposes of clarity, the first payment thereof will include a catch-up
payment covering the amount that would have otherwise been paid to the Executive during the period between the termination of Executive&rsquo;s
employment and the first payment date but for the application of this provision, and the balance of the installments (if any) will be
payable in accordance with their original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) To the extent any expense
reimbursement or in-kind benefit is determined to be subject to Section 409A, the amount of any such expenses eligible for reimbursement
or in-kind benefits provided in one taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits provided
in any other taxable year (except under any lifetime limit applicable to expenses for medical care), in no event shall any expenses be
reimbursed after the last day of the calendar year following the calendar year in which the Executive incurred such expenses, and in no
event shall any right to reimbursement or in-kind benefits be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A, the provision will be read in such a manner so that all
payments hereunder comply with Section 409A. To the extent any payment under this Agreement may be classified as a &ldquo;short-term deferral&rdquo;
within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from
Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for
purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6. <U>Non-Competition</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">The Executive acknowledges
and recognizes the highly competitive nature of the businesses of the Corporation, the amount of sensitive and confidential information
involved in the discharge of the Executive&rsquo;s position with the Corporation, and the harm to the Corporation that would result if
such knowledge or expertise was disclosed or made available to a competitor. Based on that understanding, the Executive hereby expressly
agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) As a result of the particular
nature of the Executive&rsquo;s relationship with the Corporation, in the capacities identified earlier in this Agreement, for the Term
of Employment, the Executive hereby agrees that Executive will not, directly or indirectly, (i) engage in any business for the Executive&rsquo;s
own account or otherwise derive any personal benefit from any business that competes with the business of the Corporation or any of its
affiliates (the Corporation and its affiliates are referred to, collectively, as the &ldquo;<U>Company Group</U>&rdquo;), (ii) enter the
employ of, or render any services to, any person engaged in any business that competes with the business of any entity within the Company
Group, (iii) acquire a financial interest in any person engaged in any business that competes with the business of any entity within the
Company Group, directly or indirectly, as an individual, partner, member, shareholder, officer, director, principal, agent, trustee or
consultant, or (iv) interfere with business relationships (whether formed before or after the Effective Date) between the Corporation,
any of its respective affiliates or subsidiaries, and any customers, suppliers, officers, employees, partners, members or investors of
any entity within the Company Group. For purposes of this Agreement, businesses in competition with the Company Group shall include, without
limitation, businesses which any entity within the Company Group may conduct operations, and any businesses which any entity within the
Company Group has specific plans to conduct operations in the future and as to which the Executive is aware of such planning, whether
or not such businesses have or have not as of that date commenced operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding anything
to the contrary in this Agreement, the Executive may, directly or indirectly, own, solely as an investment, securities of any Person,
other than a business that competes with the business of the Company Group, which are publicly traded on a national or regional stock
exchange or on the over-the-counter market if the Executive (i) is not a controlling Person of, or a member of a group that controls,
such Person, and (ii) does not, directly or indirectly, beneficially own one percent (1%) or more of any class of securities of such Person.
Executive may indirectly, through a mutual or exchange traded fund, own, solely as an investment, securities of a business that competes
with the business of the Company Group, which are publicly traded on a national or regional stock exchange or on the over-the-counter
market if the Executive (i) is not a controlling Person of, or a member of a group that controls, such Person, and (ii) does not, directly
or indirectly, beneficially own one percent (1%) or more of any class of securities of such business. For purposes of this&nbsp;<I>Section
6(b)</I>, &ldquo;<U>Person</U>&rdquo; shall have the meaning ascribed to such terms in Section 3(a)(9) of the Exchange Act and used in
Sections 13(d) and 14(d) thereof, including a &ldquo;group&rdquo; as described in Section 13(d) thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.&nbsp;<U>Confidential Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a material part of the
consideration for the Corporation&rsquo;s commitment to the terms of this Agreement, the Executive hereby agrees that the Executive will
not at any time (whether during or after the Executive&rsquo;s employment with the Corporation), other than in the course of the Executive&rsquo;s
duties hereunder, or unless compelled by lawful process after written notice to the Corporation of such notice along with sufficient time
for the Corporation to try and overturn such lawful process, disclose or use for the Executive&rsquo;s own benefit or purposes or the
benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity
or enterprise, any trade secrets, or other confidential data or information relating to customers, development programs, costs, marketing,
trading, investment, sales activities, promotion, credit and financial data, financing methods, or plans of any entity within the Company
Group;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the foregoing shall not apply to information which is generally known to the industry
or the public, other than as a result of the Executive&rsquo;s breach of this covenant. The Executive further agrees that the Executive
will not retain or use for Executive&rsquo;s own account, at any time, any trade names, trademark or other proprietary business designation
used or owned in connection with the business of any entity within the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8. <U>Proprietary Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Inventions</U>. All
inventions, policies, systems, developments or improvements conceived, designed, implemented and/or made by Executive, either alone or
in conjunction with others, at any time or at any place during the Term of Employment, whether or not reduced to writing or practice during
such Term of Employment, which directly or indirectly relate to the business of any entity within the Corporation and its affiliates (the
&ldquo;Company Group&rdquo;), or which were developed or made in whole or in part using the facilities and/or capital of any entity within
the Company Group, shall be the sole and exclusive property of the Company Group. Executive shall promptly give notice to the Corporation
of any such invention, development, patent or improvement, and shall at the same time, without the need for any request by any person
or entity within the Company Group, assign all of Executive&rsquo;s rights to such invention, development, patent and/or improvement to
the Company Group. Executive shall sign all instruments necessary for the filing and prosecution of any applications for, or extensions
or renewals of, letters patent of the United States or any foreign country that any entity in the Company Group desires to file.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Work Product</U>. Executive
acknowledges and agrees that all writings, works of authorship, technology, inventions, discoveries, ideas and other work product of any
nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived or reduced to practice by the Executive
individually or jointly with others during the Term of Employment by the Corporation and relating in any way to the business or contemplated
business, research or development of the Corporation (regardless of when or where the Work Product is prepared or whose equipment or other
resources is used in preparing the same) and all printed, physical and electronic copies, all improvements, rights and claims related
to the foregoing, and other tangible embodiments thereof (collectively, &ldquo;<U>Work Product</U>&rdquo;), as well as any and all rights
in and to copyrights, trade secrets, trademarks (and related goodwill), patents and other intellectual property rights therein arising
in any jurisdiction throughout the world and all related rights of priority under international conventions with respect thereto, including
all pending and future applications and registrations therefor, and continuations, divisions, continuations-in-part, reissues, extensions
and renewals thereof (collectively, &ldquo;<U>Intellectual Property Rights</U>&rdquo;), shall be the sole and exclusive property of the
Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement,
Work Product includes, but is not limited to, Company Group information, including plans, publications, research, strategies, techniques,
agreements, documents, contracts, terms of agreements, negotiations, know-how, computer programs, computer applications, software design,
web design, work in process, databases, manuals, results, developments, reports, graphics, drawings, sketches, market studies, formulae,
notes, communications, algorithms, product plans, product designs, styles, models, audiovisual programs, inventions, unpublished patent
applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer information,
client information, customer lists, client lists, manufacturing information, marketing information, advertising information, and sales
information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Work Made for Hire;
Assignment</U>. All copyrightable work by Executive during the Term of Employment that relates to the business of any entity in the Company
Group is intended to be &ldquo;work made for hire&rdquo; as defined in Section 101 of the Copyright Act of 1976, and shall be the property
of the Company Group. If the copyright to any such copyrightable work is not the property of the Company Group by operation of the law,
Executive will, without further consideration, assign to the Company Group all right, title and interest in such copyrightable work and
will assist the entities in the Company Group and their nominees in every way, at the Company Group&rsquo;s expense, to secure, maintain
and defend for the Company Group&rsquo;s benefit, copyrights and any extensions and renewals thereof on any and all such work including
translations thereof in any and all countries, such work to be and to remain the property of the Company Group whether copyrighted or
not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Further Assurances;
Power of Attorney</U>. During and after the Term of Employment, Executive agrees to reasonably cooperate with the Corporation to (i) apply
for, obtain, perfect and transfer to the Company Group the Work Product as well as an Intellectual Property Right in the Work Product
in any jurisdiction in the world; and (ii) maintain, protect and enforce the same, including, without limitation, executing and delivering
to the Corporation any and all applications, oaths, declarations, affidavits, waivers, assignments and other documents and instruments
as shall be requested by the Corporation. Executive hereby irrevocably grants the Corporation power of attorney to execute and deliver
any such documents on Executive&rsquo;s behalf in the Executive&rsquo;s name and to do all other lawfully permitted acts to transfer the
Work Product to the Corporation and further the transfer, issuance, prosecution and maintenance of all Intellectual Property Rights therein,
to the full extent permitted by law, if Executive does not promptly cooperate with the Corporation&rsquo;s request (without limiting the
rights the Corporation shall have in such circumstances by operation of law). The power of attorney is coupled with an interest and shall
not be affected by Executive&rsquo;s subsequent incapacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>No License</U>. Executive
understands that this Agreement does not, and shall not be construed to, grant the Executive any license or right of any nature with respect
to any Work Product or Intellectual Property Rights or any Confidential Information, materials, software or other tools made available
to the Executive by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.&nbsp;<U>Anti-Solicitation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of the amount of
sensitive and confidential information involved in the discharge of the Executive&rsquo;s duties, and the harm to the Corporation that
would result if such knowledge or expertise were disclosed or made available to a competitor, and as a reasonable step to help protect
the confidentiality of such information, the Executive promises and agrees that during the Term of Employment and for a period of two
(2) years thereafter, the Executive will not use the Company&rsquo;s confidential information to, directly or indirectly, individually
or as a consultant to, or as an employee, officer, shareholder, director or other owner or participant in any business, influence or attempt
to influence the customers, vendors, suppliers, joint venturers, associates, consultants, agents, or partners of any entity within the
Company Group, either directly or indirectly, to divert their business away from the Company Group, to any individual, partnership, firm,
corporation or other entity then in competition with the business of any entity within the Company Group, and he will not otherwise materially
interfere with any business relationship of any entity within the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.&nbsp;<U>Non-Solicitation of Employees</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of the amount of
sensitive and confidential information involved in the discharge of the Executive&rsquo;s duties, and the harm to the Corporation that
would result if such knowledge or expertise were disclosed or made available to a competitor, and as a reasonable step to help protect
the confidentiality of such information, the Executive promises and agrees that during the Term of Employment and for a period of one
(1) year thereafter, the Executive will not, directly or indirectly, individually or as a consultant to, or as an employee, officer, shareholder,
director, or other owner of or participant in any business, solicit (or assist in soliciting) any person who is then, or at any time within
six (6) months prior thereto was, an employee of an entity within the Company Group, who earned annually $25,000 or more as an employee
of such entity during the last six (6) months of his or her own employment to work for (as an employee, consultant or otherwise) any business,
individual, partnership, firm, corporation, or other entity whether or not engaged in competitive business with any entity in the Company
Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11. <U>Non-Disparagement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Executive agrees and covenants
that the Executive shall not at any time make, publish, or communicate to any person or entity or in any public forum any defamatory,
or maliciously false, or disparaging remarks, comments, or statements concerning the Company Group or its businesses, or any of its employees,
officers, or directors and their existing and prospective customers, suppliers, investors, and other associated third parties, now or
in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12. <U>Return of Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Executive agrees to truthfully
and faithfully account for and deliver to the Corporation all property belonging to the Corporation, any other entity in the Company Group,
or any of their respective affiliates, which Executive may receive from or on account of the Corporation, any other entity in the Company
Group, or any of their respective affiliates, and upon the termination of the Term of Employment, or the Corporation&rsquo;s demand, Executive
shall immediately deliver to the Corporation all such property belonging to the Corporation, any other entity in the Company Group, or
any of their respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13. <U>Withholding Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything else
herein to the contrary, the Corporation may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due
or payable under or pursuant to this Agreement such federal, state and local income, employment, or other taxes as may be required to
be withheld pursuant to any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. <U>Cooperation in Litigation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Executive agrees that, during
the Term of Employment or after the termination of Executive&rsquo;s employment, Executive will reasonably cooperate with the Corporation,
subject to Executive&rsquo;s reasonable personal and business schedules, in any litigation which arises out of events occurring prior
to the termination of Executive&rsquo;s employment, including but not limited to, serving as a witness or consultant and producing documents
and information relevant to the case or helpful to the Corporation. The Corporation agrees to reimburse Executive for all reasonable costs
and expenses Executive incurs in connection with her obligations under this <I>Section 9</I> and, in addition, to reasonably compensate
Executive for time actually spent in connection therewith following the termination of Executive&rsquo;s employment with the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15. <U>Miscellaneous</U>.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Assignment</U>. This Agreement is personal
in its nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights
or obligations hereunder; <U>provided</U>, <U>however</U>, that in the event of a merger, consolidation, or transfer or sale of all or
substantially all of the assets of the Corporation with or to any other individual(s) or entity, this Agreement shall, subject to the
provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all the promises,
covenants, duties, and obligations of the Corporation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Number and Gender</U>. Where the context
requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Section Headings</U>. The section headings
of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the purposes of convenience only, and they neither
form a part of this Agreement nor are they to be used in the construction or interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Governing Law</U>. This Agreement, and
all questions relating to its validity, interpretation, performance and enforcement, as well as the legal relations hereby created between
the parties hereto, shall be governed by and construed under, and interpreted and enforced in accordance with, the laws of the State of
Colorado, notwithstanding any Colorado or other conflict of law provision to the contrary. This Agreement is intended to comply with Section
409A of the Internal Revenue Code of 1986 and the regulations promulgated thereunder. Any action or proceeding by either of the parties
to enforce this Agreement shall be brought only in a state or federal court located in the State of Colorado, Boulder county. The parties
hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance
of any such action or proceeding in such venue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Severability</U>. If any provision of this
Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of this Agreement
which can be given effect without the invalid provisions or applications and to this end the provisions of this Agreement are declared
to be severable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Entire Agreement</U>. This Agreement embodies
the entire agreement of the parties hereto respecting the matters within its scope. Any prior negotiations, correspondence, agreements,
proposals or understandings relating to the subject matter hereof shall be deemed to have been merged into this Agreement, and to the
extent inconsistent herewith, such negotiations, correspondence, agreements, proposals, or understandings shall be deemed to be of no
force or effect. There are no representations, warranties, or agreements, whether express or implied, or oral or written, with respect
to the subject matter hereof, except as expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Modifications</U>. This Agreement may not
be amended, modified or changed (in whole or in part), except by a formal definitive written agreement expressly referring to this Agreement,
which agreement is executed by both of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Waiver</U>. Neither the failure nor any
delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof,
nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or
of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence
be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence. No waiver shall be effective
unless it is in writing and is signed by the party asserted to have granted such waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Resolution of Disputes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i) Any controversy arising
out of or relating to Executive&rsquo;s employment (whether or not before or after the expiration of the Term of Employment), any termination
of Executive&rsquo;s employment, this Agreement or the enforcement or interpretation of this Agreement, or because of an alleged breach,
default, or misrepresentation in connection with any of the provisions of this Agreement, including (without limitation) any state or
federal statutory claims, shall be submitted to arbitration in Denver, Colorado, before a sole arbitrator (the &ldquo;<U>Arbitrator</U>&rdquo;)
selected from the American Arbitration Association (&ldquo;<U>AAA</U>&rdquo;), and shall be conducted in accordance with the provisions
of Colorado Revised Uniform Arbitration Act as the exclusive remedy of such dispute; <U>provided</U>, <U>however</U>, that provisional
injunctive relief may, but need not, be sought in a court of law while arbitration proceedings are pending, and any provisional injunctive
relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator. Final resolution of any
dispute through arbitration may include any remedy or relief that the Arbitrator deems just and equitable, including any and all remedies
provided by applicable state or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written decision
that sets forth the essential findings and conclusions upon which the Arbitrator&rsquo;s award or decision is based. Any award or relief
granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii) The parties acknowledge
and agree that they are hereby waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the
parties against the other in connection with any matter whatsoever arising out of or in any way connected with any of the matters referenced
in the first sentence of <I>Section 15(i)(i)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iii) The parties agree that
the Corporation shall be responsible for payment of the forum costs of any arbitration hereunder, including the Arbitrator&rsquo;s fee.
The parties further agree that in any proceeding with respect to such matters, the prevailing party will be entitled to recover its reasonable
attorney&rsquo;s fees and costs from the non-prevailing party (other than forum costs associated with the arbitration which in any event
shall be paid by the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iv) Without limiting the
remedies available to the parties and notwithstanding the foregoing provisions of this <I>Section 15</I>, the Executive and the Corporation
acknowledge that any breach of any of the covenants or provisions contained in <I>Sections 6,through 11</I> could result in irreparable
injury to either of the parties hereto for which there might be no adequate remedy at law, and that, in the event of such a breach or
threat thereof, the non-breaching party shall be entitled to obtain a temporary restraining order and/or a preliminary injunction and
a permanent injunction restraining the other party hereto from engaging in any activities prohibited by any covenant or provision in <I>Sections
6 through 11</I> or such other equitable relief as may be required to enforce specifically any of the covenants or provisions of <I>Sections
6 through 11</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Publicity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">Executive hereby irrevocably
consents during the term of this Agreement to any and all uses and displays, by the Company Group and its agents, representatives and
licensees, of Executive&rsquo;s name, voice, likeness, image, appearance and biographical information in, on or in connection with any
pictures, photographs, audio and video recordings, digital images, websites, television programs and advertising, other advertising and
publicity, sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes and all other printed and electronic
forms and media throughout the world, at any time during or after the period of Executive&rsquo;s employment by the Corporation, for all
legitimate commercial and business purposes of the Company Group (&rdquo;<U>Permitted Uses</U>&rdquo;) without further consent from or
royalty, payment or other compensation to the Executive. The Executive hereby forever waives and releases the Company Group and its directors,
officers, employees and agents from any and all claims, actions, damages, losses, costs, expenses and liability of any kind, arising under
any legal or equitable theory whatsoever at any time during or after the period of Executive&rsquo;s employment by the Corporation, arising
directly or indirectly from the Company Group&rsquo;s and its agents&rsquo;, representatives&rsquo; and licensees&rsquo; exercise of their
rights in connection with any Permitted Uses. At the end of the term of this Agreement, the Corporation shall have no obligation to remove
any previously-published displays described in this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Notices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i) All notices, requests,
demands and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have been duly
received if (i) delivered by hand or by courier, effective upon delivery, (ii) given by facsimile or electronic version, when transmitted
if transmitted on a business day and during normal business hours of the recipient, and otherwise delivered on the next business day following
transmission, or (iii) sent by registered or certified mail, postage prepaid, return receipt requested, 5 business days after being deposited
in the U.S. postal mail. Any notice shall be duly addressed to the parties as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) If to the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Sonoma Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Lead Independent Director of the Board or any Independent Director<BR>
645 Molly Lane, Suite 150<BR>
Woodstock, Georgia 30189</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) If to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Amy Trombly<BR>
At the address on file with the Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii) Any party may alter the
address to which communications or copies are to be sent by giving notice of such change of address in conformity with the provisions
of this <I>Section 13</I> for the giving of notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Legal Counsel; Mutual Drafting</U>. Each
party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with
legal counsel of their choice. Each party has cooperated in the drafting, negotiation and preparation of this Agreement. Hence, in any
construction to be made of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter
of such language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Provisions that Survive Termination</U>.
The provisions of <I>Sections 3.4</I>, <I>3.5</I>, <I>5</I> through 11, 14 and this <I>Section 15</I> shall survive any termination of
the Term of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Counterparts</U>. This Agreement may be
executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon,
and all of which together shall constitute one and the same instrument. This Agreement shall become binding when one or more counterparts
hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories. Photographic
copies of such signed counterparts may be used in lieu of the originals for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Tolling</U>. Should the Executive violate
any of the terms of the restrictive covenant obligations articulated herein, the obligation at issue will run from the first date on which
the Executive ceases to be in violation of such obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Corporation and
Executive have executed this Amended and Restated Employment Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATION</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.,</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware corporation</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 52%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jerry McLaughlin</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:</P></TD>
    <TD STYLE="vertical-align: top; border-top: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jerry McLaughlin<BR>
Lead Independent Director of</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Amy Trombly</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Trombly</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT A &mdash; RELEASE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Definitions</U>.
I intend all words used in this Release to have their plain meanings in ordinary English. Technical legal words are not needed to describe
what I mean. Specific terms I use in this Release have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. &ldquo;I,&rdquo; &ldquo;me,&rdquo;
and &ldquo;my&rdquo; include me, Amy Trombly, and anyone who has or obtains any legal rights or claims through me, including my heirs
and estate, and each of my descendants, dependents, executors, administrators, assigns and successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. &ldquo;Employer,&rdquo;
as used in this Release, shall at all times mean Sonoma Pharmaceuticals, Inc. and &ldquo;Released Party&rdquo; or &ldquo;Released Parties&rdquo;,
individual and collectively, means the Employer and the Employer&rsquo;s parent, past or present subsidiaries, affiliates, each of any
present or former officers, directors, shareholders, employees, agents or attorneys, trustees, insurers, successors, predecessors, assigns,
or personal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. &ldquo;My Claims&rdquo;
mean actions or causes of action, suits, claims, charges, complaints, contracts (whether oral or written, express or implied from any
source), and promises, whatsoever, in law or equity, that I ever had, may now have or hereafter can, shall or may have against the Employer
or other Released Party as of the date of the execution of this Release, including all unknown, undisclosed and unanticipated losses,
wrongs, injuries, debts, claims or damages to me for, upon, or by reason of any matter, cause or thing whatsoever, that are in any way
related to my employment with or separation (termination of employment) from the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing this Release, I
am agreeing to release any actual and potential claim, known or unknown, I have or may potentially have, in law or in equity, either as
an individual or standing in the shoes of the government, under any federal, state or local law, administrative regulation or legal principle
(except as provided in Paragraph 4 of this Release). The following listing of laws and types of claims is not meant to, and shall not
be interpreted to, exclude any particular law or type of claim, law, regulation or legal principle not listed. I understand I am releasing
all my Claims, including, but not limited to, claims for invasion of privacy; breach of written or oral, express or implied, contract;
fraud or misrepresentation; and any claim under Section 1981 of the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964,
Age Discrimination in Employment Act of 1967 (&ldquo;ADEA&rdquo;), 29 U.S.C. &sect; 626, as amended, the Older Workers Benefit Protection
Act of 1990 (&ldquo;OWBPA&rdquo;), 29 U.S.C. 626(f), Title VII of the Civil Rights Act of 1964 (&ldquo;Title VII&rdquo;), 42 U.S.C. &sect;
2000e, et seq., the Americans with Disabilities Act Amendments Act (&ldquo;ADAAA&rdquo;), 29 U.S.C. &sect; 2101, et seq., the Family and
Medical Leave Act (&ldquo;FMLA&rdquo;), 29 U.S.C. &sect; 2601 et seq., the Employee Retirement Income Security Act of 1974 (&ldquo;ERISA&rdquo;),
as amended, 29 U.S.C. &sect;&sect; 1001, et seq., Equal Pay Act (&ldquo;EPA&rdquo;), 29 U.S.C. &sect; 206(d), the Worker Adjustment and
Retraining Notification Act (&ldquo;WARN&rdquo;), 29 U.S.C. &sect; 2101 et seq., the False Claims Act, 31 U.S.C. &sect; 3729 et seq.,
the Colorado Anti-Discrimination Act (CADA), the Workplace Accommodations for Nursing Mothers Act, the Pregnant Workers Fairness Act,
the Lawful Off-Duty Activities Statute (LODA), the Personnel Files Employee Inspection Right Statute, the Colorado Labor Peace Act, the
Colorado Labor Relations Act, the Colorado Equal Pay Act, the Colorado Minimum Wage Order, the Colorado Genetic Information Non-Disclosure
Act, any other state human rights or fair employment practices act, and any other federal, state, or local statute, law, rule, regulation,
ordinance or order. This includes, but is not limited to, claims for violation of any civil rights laws based on protected class status;
claims for assault, battery, defamation, intentional or negligent infliction of emotional distress, breach of the covenant of good faith
and fair dealing, promissory estoppel, negligence, negligent hiring, retention or supervision, retaliation, constructive discharge, violation
of whistleblower protection laws, unjust enrichment, payment of any kind, including any other claim for severance pay, bonus or incentive
pay, sick leave, holiday pay, vacation pay, life insurance, health or medical insurance or any other fringe benefit, medical expenses,
or disability, violation of public policy, and all other claims for unlawful employment practices, and all other common law or statutory
claims. To the maximum extent permitted by law, I agree that I will not seek and waive any right to accept any relief or award from any
charge or action against the Employer before any federal, state, or local administrative agency or federal state or local court whether
filed by me or on my behalf with respect to any claim or right covered by this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;<U>Agreement to Release
My Claims</U>. Except as stated in Paragraph 4, I agree to give up all My Claims, waive any rights thereunder, and forever discharge the
Employer and all Released Parties of and from any and all liability to me for actions or causes of action, suits, or Claims. To the maximum
extent permitted by law, I agree that I will not seek and I waive any right to accept any relief or award from any charge or action against
the Employer or other Released Party before any federal, state, or local administrative agency or federal state or local court whether
filed by me or on my behalf with respect to any claim or right covered by this Release. I also agree to withdraw any and all of my charges
and lawsuits against Employer or other Released Party, except that I may, but am not required to, withdraw or dismiss, or attempt to withdraw
or dismiss, any charges that I may have pending against the Employer or other Released Party with the EEOC or other civil rights enforcement
agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I represent and warrant that
I have not transferred or otherwise assigned my Claims, or parts thereof, to any person or entity, other than the Employer. I will defend,
indemnify and hold harmless the Employer from and against any claim (including the payment of attorneys&rsquo; fees and costs actually
incurred whether or not litigation is commenced) that is directly or indirectly based on or in connection with or arising out of any such
assignment or transfer made, purported or claimed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;In exchange for my agreement
to release my Claims, I am receiving satisfactory Consideration (compensation) from the Employer to which I am not otherwise entitled
by law, contract, or under any Employer policy. The consideration I am receiving is a full and fair payment for the release of all my
Claims. The Employer and the Released Parties do not owe me anything in addition to what I will be receiving.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&nbsp;<U>Older Workers Benefit
Protection Act</U>. [This section may be revised if Executive terminates employment as part of a &ldquo;group&rdquo; termination.] The
Older Workers Benefit Protection Act (&ldquo;OWBPA&rdquo;) applies to individuals age 40 and older and sets forth certain criteria for
such individuals to waive their rights under the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;) in connection with an exit
incentive program or other employment termination program. I understand and have been advised that this Release of My Claims is subject
to the terms of the OWBPA. The OWBPA provides that an individual cannot waive a right or claim under the ADEA unless the waiver is knowing
and voluntary. I have been advised of this law, and I agree that I am signing this Release voluntarily, and with full knowledge of its
consequences. I understand that the Employer is giving me at least twenty-one (21) calendar days from the date I received a copy of this
Release to decide whether I want to sign it. I acknowledge that I have been advised to use this time to consult with an attorney about
the effect of this Release. If I sign this Release before the end of the twenty-one (21) day period it will be my personal, voluntary
decision to do so, and will be done with full knowledge of my legal rights. I agree that material and/or immaterial changes to the Separation
Agreement or this Release will not restart the running of this consideration period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<U>Exclusions from
Release</U>. My Claims do not include my rights, if any, to claim the following: unemployment insurance or workers compensation benefits;
claims for my vested post-termination benefits under any 401(k) or similar tax-qualified retirement benefit plan; my COBRA rights; and
my rights to enforce the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. Nothing in this Release
interferes with my right to file a charge with the Equal Employment Opportunity Commission (&ldquo;EEOC&rdquo;) or other local civil rights
enforcement agency, or participate in any manner in an EEOC investigation or proceeding under Title VII, the ADA, the ADEA, or the EPA.
I, however, understand that I am waiving my right to recover individual relief including, but not limited to, back pay, front pay, reinstatement,
attorneys&rsquo; fees, and/or punitive damages, in any administrative or legal action whether brought by the EEOC or other civil rights
enforcement agency, me or any other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. Nothing in this Release
interferes with my right to challenge the knowing and voluntary nature of this Release under the ADEA and/or OWBPA, if I have rights under
such laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. I agree that the Employer
and the Released Parties reserve any and all defenses, which any of them has or might have against any claims brought by me. This includes,
but is not limited to, the Employer&rsquo;s or other Released Party&rsquo;s right to seek available costs and attorneys&rsquo; fees, and
to have any monetary award granted to me, if any, reduced by the amount of money that I received in consideration for this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. Nothing in this Release
releases any claims for indemnification by Executive pursuant to any indemnification agreement, statute or otherwise or claims for coverage
under any D&amp;O or other similar insurance policy.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&nbsp;<U>Effective Date;
Right to Rescind or Revoke</U>. I understand that insofar as this Release relates to my rights under the Age Discrimination in Employment
Act (&ldquo;ADEA&rdquo;), it shall not become effective or enforceable until seven (7) calendar days after I sign it. I also have the
right to rescind (or revoke) this Release insofar as it extends to potential claims under the ADEA by written notice to Employer within
seven (7) calendar days following my signing this Release (the &ldquo;Rescission Period&rdquo;). Any such rescission (or revocation) must
be in writing and hand-delivered to Employer or, if sent by mail, postmarked within the applicable time period, sent by certified mail,
return receipt requested, and addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. post-marked within the
seven (7) calendar day Rescission Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. properly addressed to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">[INSERT NAME AND ADDRESS];
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. sent by certified mail,
return receipt requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&nbsp;<U>I Understand the
Terms of this Release</U>. I have had the opportunity to read this Release carefully and understand all its terms. I have had the opportunity
to review this Release with my own attorney. In agreeing to sign this Release, I have not relied on any statements or explanations made
by the Employer or its attorneys. I understand and agree that this Release and the attached Agreement contain all the agreements between
the Employer (and any other Released Party) and me. We have no other written or oral agreements. I understand this Release is a very important
legal document and I agree to be bound by the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 46%">&nbsp;</TD>
    <TD STYLE="width: 53%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ____________, 20__</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amy Trombly</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>snoa_ex1002.htm
<DESCRIPTION>AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND BRUCE THORNTON, DATED JULY 22, 2022.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>Exhibit 10.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>AMENDED AND RESTATED EMPLOYMENT AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This AMENDED AND RESTATED
EMPLOYMENT AGREEMENT (this &ldquo;<U>Agreement</U>&rdquo;) is entered into by and between Bruce Thornton (the &ldquo;<U>Executive</U>&rdquo;),
and Sonoma Pharmaceuticals, Inc., a Delaware corporation (the &ldquo;<U>Corporation</U>&rdquo;), as of July 22, 2022 (the &ldquo;<U>Effective
Date</U>&rdquo;). This Agreement replaces that certain employment agreement dated as of July 1, 2021, and entered into by and between
the Executive and the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Corporation
desires that the Executive continue to be employed by the Corporation as its Executive Vice President of International Operations and
Sales and Chief Operating Officer, and to carry out the duties and responsibilities described below, all on the terms and conditions set
forth herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Executive
is willing to accept and continue such employment on such terms and conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the foregoing premises and the mutual covenants and promises of the parties herein, the receipt and sufficiency of which
are hereby acknowledged by each of the parties, the Corporation and the Executive hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. <U>Employment and Duties</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1 <U>Position</U>. On the
terms and subject to the conditions set forth herein, the Corporation agrees to continue to employ the Executive as its Executive Vice
President of International Operations and Sales and Chief Operating Officer for the Term of Employment (as defined in <I>Section 2</I>).
The Executive does hereby accept and agree to such employment, on the terms and conditions expressly set forth in this Agreement. The
Executive shall, if requested, also serve as a member of the Board of Directors of the Corporation (the &ldquo;<U>Board</U>&rdquo;) or
as an officer or director of any affiliate of the Corporation for no additional compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.2 <U>Duties</U>. During
the Term of Employment (as defined in <I>Section 2</I>), the Executive shall serve the Corporation as its Executive Vice President of
International Operations and Sales and Chief Operating Officer. The Executive shall, without limitation and without limiting the Executive&rsquo;s
other duties to the Corporation, and without limiting the authority of the Corporation&rsquo;s Board of Directors, be responsible for
the general supervision, direction and control of the business and affairs of the Corporation and have such other duties and responsibilities
as the Board shall designate that are consistent with the Executive&rsquo;s position as Executive Vice President of International Operations
and Sales of the Corporation. The Executive shall perform all of such duties and responsibilities in accordance with the legal directives
of the Board and in accordance with the practices and policies of the Corporation as in effect from time to time throughout the Term of
Employment (as defined in <I>Section 2</I>) (including, without limitation, the Corporation&rsquo;s insider trading and ethics policies,
as they may change from time to time). While employed as Executive Vice President of International Operations and Sales of the Corporation,
the Executive shall report exclusively to the Board. Throughout the Term of Employment (as defined in <I>Section 2</I>), the Executive
shall not serve on the boards of directors or advisory boards of any other entity, except for any wholly or majority owned subsidiaries
of the Corporation, unless such service is expressly approved by the Board. As Executive Vice President of International Operations and
Sales and Chief Operating Officer, Mr. Thornton is responsible for operations, partner management and sales, manufacturing, R&amp;D, regulatory
compliance and quality control for the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.3 <U>No Other Employment;
Minimum Time Commitment</U>. Throughout the Term of Employment, the Executive shall both (i) devote substantially all of the Executive&rsquo;s
business time, energy and skill to the performance of the Executive&rsquo;s duties for the Corporation, and (ii) hold no other job. The
Executive agrees that any investment or direct involvement in, or any appointment to or continuing service on the board of directors or
similar body of, any corporation or other entity, other than wholly or majority owned subsidiaries of the Corporation, must be first approved
in writing by the Corporation. The foregoing provisions of this <I>Section 1.3</I> shall not prevent the Executive from investing in non-competitive,
publicly-traded securities to the extent permitted by <I>Section 6(b)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.4 <U>No Breach of Contract</U>.
The Executive hereby represents to the Corporation that: (i) the execution and delivery of this Agreement by the Executive and the Corporation
and the performance by the Executive of the Executive&rsquo;s duties hereunder shall not constitute a breach of, or otherwise contravene,
the terms of any other agreement or policy to which the Executive is a party or otherwise bound; (ii) the Executive has no information
(including, without limitation, confidential information and trade secrets) of any other person or entity which the Executive is not legally
and contractually free to disclose to the Corporation; and (iii) the Executive is not bound by any confidentiality, trade secret or similar
agreement (other than this Agreement) with any other person or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.5 <U>Place of Performance</U>.
The principal place of Executive&rsquo;s employment shall be the Corporation&rsquo;s principal executive offices, currently located in
Woodstock, Georgia, though such principal place of employment of the Executive may be moved from time to time upon mutual agreement by
the Executive and the Corporation; however, Executive may work remotely as long as he is available to be present at the Corporation&rsquo;s
principal executive offices if required by the Corporation. The Executive agrees that the Executive will be regularly present at the Corporation&rsquo;s
principal executive offices, or such other location as the parties may designate, and that the Executive may be required to travel from
time to time in the course of performing the Executive&rsquo;s duties for the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.6 <U>Performance Review</U>.
During the Term of Employment, the Compensation Committee of the Corporation, in its sole discretion, will review Executive&rsquo;s performance
every twelve (12) months beginning on the Effective Date. The Compensation Committee will determine the performance goals and factors
after consultation with the Executive in its sole discretion and its decision shall be binding on all persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <U>Term of Employment</U>. The &ldquo;<U>Term
of Employment</U>&rdquo; shall commence on the Effective Date, and shall continue in full force and effect until the Termination Date
pursuant to <I>Section 5.8</I>. This Agreement shall govern the terms of Executive&rsquo;s employment hereunder on and after the Effective
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <U>Compensation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1 <U>Base Salary</U>. As
of the Effective Date and during the Term of Employment, the Corporation shall pay to the Executive a base salary at the rate of $250,000
per year, subject to increase (but not decrease) by the Board (the &ldquo;<U>Base Salary</U>&rdquo;). The Executive&rsquo;s Base Salary
shall be paid in accordance with the Corporation&rsquo;s regular payroll practices in effect from time to time, but no less frequently
than monthly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2 <U>Annual Bonus</U>. For
each fiscal year during the Term of Employment, Executive shall be eligible to receive a target annual bonus (the &ldquo;<U>Annual Bonus</U>&rdquo;)
of 50% of Base Salary, up to 120% of the target Annual Bonus. However, the decision to provide any Annual Bonus and the amount and terms
of any Annual Bonus shall be in the sole and absolute discretion of the Compensation Committee of the Board. Executive must be employed
by the Corporation on the day that any Annual Bonus is paid. However, the Board of Directors or the Compensation Committee, as appropriate,
may in its sole discretion agree to pay a pro rata or full Annual Bonus, and if such Annual Bonus is granted, then determine the amount,
form and payment schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.3 <U>Equity Awards</U>.
During the Term of Employment, Executive shall be eligible to participate in the Corporation&rsquo;s equity incentive plans in effect
at the time, subject to the terms of such plans, as determined by the Board or the Compensation Committee, in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.4. <U>Indemnification.</U>
(a) In the event that the Executive is made a party or threatened to be made a party to any action, suit, or proceeding, whether civil,
criminal, administrative or investigative (a &ldquo;<U>Proceeding</U>&rdquo;), other than any Proceeding initiated by the Executive or
the Corporation related to any contest or dispute between the Executive and the Corporation or any of its affiliates with respect to this
Agreement or the Executive&rsquo;s employment hereunder, by reason of the fact that the Executive is or was a director or officer of the
Corporation, or any affiliate of the Corporation, or is or was serving at the request of the Corporation as a director, officer, member,
employee or agent of another corporation or a partnership, joint venture, trust or other enterprise, the Executive shall be indemnified
and held harmless by the Corporation to the maximum extent permitted under applicable law and the Corporation&rsquo;s articles and bylaws,
as may be amended from time to time, from and against any liabilities, costs, claims and expenses, including all costs and expenses incurred
in defense of any Proceeding (including attorneys&rsquo; fees).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) During the Term of Employment
and for a period of six (6) years thereafter, the Corporation or any successor to the Corporation shall purchase and maintain, at its
own expense, directors&rsquo; and officers&rsquo; liability insurance providing coverage to the Executive on terms that are no less favorable
than the coverage provided to other directors and similarly situated executives of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.5 <U>Clawback Provisions</U>.
Any incentive-based compensation, or any other compensation, paid to the Executive pursuant to this Agreement or any other agreement or
arrangement with the Corporation which is subject to recovery under any law, government regulation or stock exchange listing requirement,
will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange
listing requirement (or any policy adopted by the Corporation pursuant to any such law, government regulation or stock exchange listing
requirement). The Corporation will make any determination for clawback or recovery in accordance with any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4. <U>Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1 <U>Health and Welfare</U>.
During the Term of Employment, Executive shall be entitled to participate in all employee pension and welfare benefit plans and programs
made available by the Corporation to the Corporation&rsquo;s senior-level employees generally, as such plans or programs may be in effect
from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2 <U>Reimbursement of Business
Expenses</U>. Executive is authorized to incur reasonable expenses in carrying out the Executive&rsquo;s duties for the Corporation under
this Agreement and entitled to reimbursement for all such expenses the Executive incurs during the Term of Employment in connection with
carrying out the Executive&rsquo;s duties for the Corporation, subject to the Corporation&rsquo;s reasonable expense reimbursement policies
in effect from time to time. The Corporation shall reimburse the Executive to the extent required by the preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3 <U>Vacation and Other
Leave</U>. During the Term of Employment, Executive shall accrue and be entitled to take paid vacation in accordance with the Corporation&rsquo;s
standard vacation policies in effect from time to time, including the Corporation&rsquo;s policies regarding vacation accruals. The Executive
shall also be entitled to all other holiday and leave pay generally available to all other employees of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4. <U>Car allowance</U>.
During the Term of Employment, Executive shall be entitled to a car allowance in the amount of $900 per month. The Corporation reserves
the right to review the amount of the car allowance annually and to determine whether to continue paying such car allowance and in what
amount. The Corporation may, in its sole discretion, increase, decrease or eliminate the car allowance at any time. The car allowance
is intended to be a fixed amount and any car expenses in excess of the monthly payment shall be borne by the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5. <U>Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Term of Employment and
the Executive&rsquo;s employment hereunder may be terminated by either the Corporation or the Executive at any time and for any reason;
provided that, unless otherwise provided herein, either party shall be required to give the other party at least 30 calendar days advance
written notice of any termination of the Executive&rsquo;s employment in accordance with <I>Sections 5.7</I> and <I>5.8</I>. Upon termination
of the Executive&rsquo;s employment during the Term of Employment, the Executive shall be entitled to the compensation and benefits described
in this <I>Section 5 </I>and shall have no further rights to any compensation or any other benefits from the Company or any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;5.1 <U>Definitions</U>.
For purposes of this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">(a) &ldquo;<U>Accrued Amounts</U>&rdquo;
shall mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-align: justify">(i)&nbsp;&nbsp;any accrued but unpaid
Base Salary and accrued but unused vacation which shall be paid within one (1) week following the Termination Date (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii)&nbsp;&nbsp;reimbursement for unreimbursed
business expenses properly incurred by the Executive, which shall be subject to and paid in accordance with the Corporation&rsquo;s expense
reimbursement policy; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iii)&nbsp;&nbsp;such employee benefits
(including equity compensation), if any, to which the Executive may be entitled under the Corporation&rsquo;s employee benefit plans as
of the Termination Date; provided that, in no event shall the Executive be entitled to any payments in the nature of severance or termination
payments except as specifically provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">(b) &ldquo;<U>Change in Control</U>&rdquo;
shall mean the occurrence of any of the following after the Effective Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i)&nbsp;&nbsp;one person (or more than
one person acting as a group) acquires ownership of stock of the Company that, together with the stock held by such person or group, constitutes
more than 50% of the total fair market value or total voting power of the stock of such corporation; provided that, a Change in Control
shall not occur if any person (or more than one person acting as a group) owns more than 50% of the total fair market value or total voting
power of the Company&rsquo;s stock and acquires additional stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii)&nbsp;&nbsp;a majority of the members
of the Board are replaced during any twelve-month period by directors whose appointment or election is not endorsed by a majority of the
Board before the date of appointment or election; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iii)&nbsp;&nbsp;the sale of all or substantially
all of the Company&rsquo;s assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">Notwithstanding the foregoing, a Change
in Control shall not occur unless such transaction constitutes a change in the ownership of the Company, a change in effective control
of the Company, or a change in the ownership of a substantial portion of the Company&rsquo;s assets under Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 63pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">For purposes of the definition of &ldquo;<U>Change
of Control</U>&rdquo;, the following definitions shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i) The term &ldquo;person&rdquo; shall
mean any individual, corporation or other entity and any group as such term is used in Section 13(d) (3) or 14(d) (2) of the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii)&nbsp;&nbsp;Any person shall be deemed
to be the beneficial owner of any shares of capital stock of the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">a. which that person owns directly
whether or not of record, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">b. which that person has the right
to acquire pursuant to any agreement or understanding or upon exercise of conversion rights, warrants, or options, or otherwise, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">c. which are beneficially owned, directly
or indirectly (including shares deemed owned through application of clause (b) above, by an &ldquo;affiliate&rdquo; or &ldquo;associate&rdquo;
(as defined in the rules of the Securities and Exchange Commission under the Securities Act of 1933, as amended) of that person, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 94.5pt; text-align: justify">d. which are beneficially owned, directly
or indirectly (including shares deemed owned through application of clause (b) above), by any other person with which that person or his
&ldquo;affiliate&rdquo; or &ldquo;associate&rdquo; (defined as aforesaid) has any agreement, arrangement, or understanding for the purpose
of acquiring, holding, voting or disposing of capital stock of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iii)&nbsp;&nbsp;The outstanding shares
of capital stock of the Corporation shall include shares deemed owned through application of clause (ii) (b), (c), and (d) above, but
shall not include any other shares which may be issuable pursuant to any agreement or upon exercise of conversion rights, warrants or
options, or otherwise, but which are not actually outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.5pt; text-align: justify">(c) &ldquo;<U>Cause</U>&rdquo; shall
mean:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i)&nbsp;&nbsp;the Executive&rsquo;s
willful failure to perform his duties (other than any such failure resulting from incapacity due to physical or mental illness);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii)&nbsp;&nbsp;the Executive&rsquo;s
willful failure to comply with any valid and legal directive of the Board communicated to him in writing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iii)&nbsp;&nbsp;the Executive&rsquo;s
willful engagement in dishonesty, illegal conduct or gross misconduct, which is, in each case, materially injurious to the Company or
its affiliates;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iv)&nbsp;&nbsp;the Executive&rsquo;s
embezzlement, misappropriation or fraud, whether or not related to the Executive&rsquo;s employment with the Corporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(v)&nbsp;&nbsp;the Executive&rsquo;s
conviction of or plea of guilty or <I>nolo contendere</I> to a crime that constitutes a felony (or state law equivalent) or a crime that
constitutes a misdemeanor involving moral turpitude;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(vi)&nbsp;&nbsp;the Executive&rsquo;s
violation of a material policy of the Corporation that has been provided to Executive (documents made public on the Company&rsquo;s website
or through filings with the U.S. Securities and Exchange Commission are deemed provide to the Executive);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(vii)&nbsp;&nbsp;the Executive&rsquo;s
willful unauthorized disclosure of Confidential Information (as defined below);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(viii)&nbsp;&nbsp;the Executive&rsquo;s
material breach of any material obligation under this Agreement or any other written agreement between the Executive and the Corporation;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ix)&nbsp;&nbsp;any material failure
by the Executive to comply with the Corporation&rsquo;s written policies or rules, as they may be in effect from time to time during the
Employment Term, if such failure causes material, reputational or financial harm to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">For purposes of this provision,
no act or failure to act on the part of the Executive shall be considered &ldquo;willful&rdquo; unless it is done, or omitted to be done,
by the Executive in bad faith or without reasonable belief that the Executive&rsquo;s action or omission was in the best interests of
the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or upon the advice
of counsel for the Corporation shall be conclusively presumed to be done, or omitted to be done, by the Executive in good faith and in
the best interests of the Corporation. In all cases the Company shall notify the Executive in writing of the basis for any for Cause termination
by providing a detailed description of the alleged facts and circumstances giving rise to Cause. In addition, with respect to clauses
(i), (ii), (vi), (viii) and (ix) Executive shall be given a period of at least 30 days to cure and only if Executive fails to cure within
such time period will a termination be for Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 49.5pt">(d) &ldquo;<U>Disability</U>&rdquo;
shall mean the Executive&rsquo;s inability, due to physical or mental incapacity, to substantially perform his duties and responsibilities
under this Agreement, with or without reasonable accommodation, for 90 calendar days out of any three hundred sixty-five (365) calendar
day period, but only if the Executive is considered disabled within the meaning of Treasury Regulation section 1.409A-3(i)(4). Without
limiting the circumstances in which the Executive may be determined to be disabled as defined in Treasury Regulation section 1.409A-3(i)(4),
the Executive will be presumed to be disabled if determined to be totally disabled by the Social Security Administration or if determined
to be disabled in accordance with a disability insurance program, provided the definition of disability applied under such disability
insurance program complies with the requirements of Treasury Regulation section 1.409A-3(i)(4). Any question as to the existence of the
Executive&rsquo;s Disability as to which the Executive and the Corporation cannot agree shall be determined in writing by a qualified
independent physician mutually acceptable to the Executive and the Corporation. If the Executive and the Corporation cannot agree as to
a qualified independent physician, each shall appoint such a physician and those two physicians shall select a third who shall make such
determination in writing. The determination of Disability made in writing to the Corporation and the Executive shall be final and conclusive
for all purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 49.5pt">(e) &ldquo;<U>Good Reason</U>&rdquo;
shall mean the occurrence of any of the following, in each case during the Employment Term without the Executive&rsquo;s written consent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i)&nbsp;&nbsp;a reduction in the Executive&rsquo;s
then current Base Salary;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii)&nbsp;&nbsp;only after a sale of
the Corporation, a relocation of the Executive&rsquo;s principal place of employment by more than 50 miles, unless the new principal place
of employment is closer to Executive&rsquo;s principal residence;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iii)&nbsp;&nbsp;the Corporation&rsquo;s
failure to obtain an agreement from any successor to the Corporation to assume and agree to perform this Agreement in the same manner
and to the same extent that the Corporation would be required to perform if no succession had taken place, except where such assumption
occurs by operation of law; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(iv)&nbsp;&nbsp;a material, adverse change
in the Executive&rsquo;s title, authority, duties or responsibilities (other than temporarily while the Executive is physically or mentally
incapacitated or as required by applicable law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">The Executive cannot terminate
his employment for Good Reason unless he has provided written notice to the Corporation of the existence of the circumstances providing
grounds for termination for Good Reason within 30 business days of the initial existence of such grounds and the Corporation has had at
least 30 business days from the date on which such notice is provided to cure such circumstances. If the Executive does not terminate
his employment for Good Reason within 30 calendar days after the expiration of the cure period, then the Executive will be deemed to have
waived his right to terminate for Good Reason with respect to such grounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;&nbsp;<U>Termination
for Cause or Without Good Reason</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt">The Executive&rsquo;s employment
hereunder may be terminated by the Corporation for Cause or by the Executive without Good Reason. If the Executive&rsquo;s employment
is terminated, by the Corporation for Cause or by the Executive without Good Reason, the Executive shall be entitled to receive the Accrued
Amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3 <U>Termination Without
Cause or for Good Reason</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">The Term of Employment and
the Executive&rsquo;s employment hereunder may be terminated by the Executive for Good Reason or by the Corporation without Cause. In
the event of such termination, the Executive shall be entitled to receive the Accrued Amounts and subject to the Executive&rsquo;s compliance
with <I>Sections 6 through 11</I> of this Agreement and his execution of a release of claims in favor of the Company, its affiliates and
their respective officers and directors in a form attached hereto (the &ldquo;<U>Release</U>&rdquo;) and such Release becoming effective
within the applicable time period set forth in the Release, (the &ldquo;<U>Release Execution Period</U>&rdquo;), the Executive shall be
entitled to receive the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a lump sum payment equal to one time the Executive&rsquo;s Base Salary, which shall be paid on the 30<SUP>th</SUP> day following the Termination Date; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon determination by the Corporation&rsquo;s Board of Directors or Compensation Committee, as appropriate, to be made in its sole discretion as to whether to grant a bonus, and if such bonus is granted, the amount, form and payment schedule. For the avoidance of doubt, Executive shall not be entitled to any bonus solely for reason of termination, unless the Board of Directors or the Compensation Committee, as appropriate, in its sole discretion awards a bonus to Executive.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(c) &nbsp;&nbsp;If the Executive
timely and properly elects health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (&ldquo;<U>COBRA</U>&rdquo;),
the Company shall reimburse the Executive for the monthly COBRA premium paid by the Executive for himself and his dependents. Such reimbursement
shall be paid to the Executive on the 10<SUP>th</SUP> day of the month immediately following the month in which the Executive timely remits
the premium payment (&ldquo;<U>COBRA Premium Reimbursements</U>&rdquo;). The Executive shall be eligible to receive such COBRA Premium
Reimbursement until the earliest of: (i) the twelve-month anniversary of the Termination Date; (ii) the date the Executive is no longer
eligible to receive COBRA continuation coverage; and (iii) the date on which the Executive becomes eligible to receive substantially similar
coverage from another employer or other source. Notwithstanding the foregoing, if the Company&rsquo;s making payments under this <I>Section
5.3(c)</I> would violate the nondiscrimination rules applicable to non-grandfathered plans under the Affordable Care Act (the &ldquo;<U>ACA</U>&rdquo;),
or result in the imposition of penalties under the ACA and the related regulations and guidance promulgated thereunder), the parties agree
to reform this <I>Section 5.3(c)</I> in a manner as is necessary to comply with the ACA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(d) &nbsp;&nbsp;Consistent
with the terms of any equity incentive plan of the Company, as approved by the stockholders, as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i) &nbsp;&nbsp;all outstanding time-based
equity-based compensation awards granted to the Executive during the Term of Employment shall become fully vested and exercisable for
the remainder of their full term; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii) &nbsp;&nbsp;all outstanding performance-based
equity compensation awards granted to the Executive during the Term of Employment shall remain outstanding and shall vest or be forfeited
in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied. The determination
whether such performance goals are satisfied shall be in the sole discretion of the Compensation Committee or the Board, as the case may
be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4 &nbsp;&nbsp;<U>Death or
Disability</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(a) &nbsp;&nbsp;The Executive&rsquo;s
employment hereunder shall terminate automatically upon the Executive&rsquo;s death during the Term of Employment, and the Corporation
may terminate the Executive&rsquo;s employment on account of the Executive&rsquo;s Disability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(b) &nbsp;&nbsp;If the Executive&rsquo;s
employment is terminated during the Term of Employment on account of the Executive&rsquo;s death or Disability, the Executive (or the
Executive&rsquo;s estate and/or beneficiaries, as the case may be) shall be entitled to receive the Accrued Amounts. In addition, Executive&rsquo;s
spouse and other dependents shall be entitled to 12 months of COBRA Premium Reimbursements upon timely request to the Corporation for
such benefits. Notwithstanding any other provision contained herein, all payments made in connection with the Executive&rsquo;s Disability
shall be provided in a manner which is consistent with federal and state law. The Corporation may deduct, from all payments made hereunder,
all applicable taxes and other appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5 &nbsp;&nbsp;<U>Change
in Control Termination</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(a) &nbsp;&nbsp;Notwithstanding
any other provision contained herein, if the Executive&rsquo;s employment hereunder is terminated by the Executive for Good Reason or
without Cause (other than on account of the Executive&rsquo;s death or Disability), in each case within three (3) months prior to or twelve
(12) months following a Change in Control, the Executive shall be entitled to receive: (i) the Accrued Amounts; (ii) subject to the Executive&rsquo;s
compliance with <I>Sections 6 through 11</I> of this Agreement and his execution of a Release which becomes effective by the end of the
Release Execution Period, a lump sum payment equal to one time the sum of the Executive&rsquo;s Base Salary, which shall be paid on the
30<SUP>th</SUP> day following the Termination Date; and (iii) the target Annual Bonus amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(b) &nbsp;&nbsp;If the Executive
timely and properly elects health continuation coverage under COBRA, the Corporation shall reimburse the Executive for the monthly COBRA
premium paid by the Executive for himself and his dependents. Such reimbursement shall be paid to the Executive on the 10<SUP>th</SUP>
day of the month immediately following the month in which the Executive timely remits the premium payment. The Executive shall be eligible
to receive such reimbursement until the earliest of: (i) the twelve-month anniversary of the Termination Date; (ii) the date the Executive
is no longer eligible to receive COBRA continuation coverage; and (iii) the date on which the Executive becomes eligible to receive substantially
similar coverage from another employer or other source. Notwithstanding the foregoing, if the Corporation&rsquo;s making payments under
this <I>Section 5.5(b)</I> would violate the nondiscrimination rules applicable to non-grandfathered plans under the ACA, or result in
the imposition of penalties under the ACA, the parties agree to reform this <I>Section 5.5(b)</I> in a manner as is necessary to comply
with the ACA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40pt">(c) &nbsp;&nbsp;Consistent
with the terms of any equity incentive plan of the Company, as approved by the stockholders, as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(i) &nbsp;&nbsp;all outstanding time-based
equity-based compensation awards granted to the Executive during the Term of Employment shall become fully vested and exercisable for
the remainder of their full term; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60pt; text-align: justify">(ii) &nbsp;&nbsp;all outstanding performance-based
equity compensation awards granted to the Executive during the Term of Employment shall remain outstanding and shall vest or be forfeited
in accordance with the terms of the applicable award agreements, if the applicable performance goals are satisfied. The determination
whether such performance goals are satisfied shall be in the sole discretion of the Compensation Committee or the Board, as the case may
be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6 &nbsp;&nbsp;<U>Release; Exclusive
Remedy</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) The Executive agrees that
the payments contemplated by <I>Section 5</I> shall constitute the exclusive and sole remedy for any termination of his employment and
the Executive covenants not to assert or to pursue any other remedies, at law or in equity, with respect to any termination of employment.
The Corporation and Executive acknowledge and agree that there is no duty of the Executive to mitigate damages under this Agreement. All
amounts paid to the Executive pursuant to <I>Section 5</I> shall be paid without regard to whether the Executive has taken or takes actions
to mitigate damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) As used herein, &ldquo;<U>Release</U>&rdquo;
shall mean a written release, discharge and covenant not to sue entered into by the Executive in favor of the Corporation in the form
as in <U>Exhibit A</U> hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7&nbsp;&nbsp; <U>Notice of Termination</U>.
Any termination of the Executive&rsquo;s employment hereunder by the Company or by the Executive during the Term of Employment (other
than termination pursuant to <I>Section 5.4</I> on account of the Executive&rsquo;s death) shall be communicated by written notice of
termination (the &ldquo;<U>Notice of Termination</U>&rdquo;) to the other party hereto in accordance with <I>Section 14(j)</I>. The Notice
of Termination shall specify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The termination provision of this Agreement relied upon;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To the extent applicable, the facts and circumstances claimed to provide a basis for termination of the Executive&rsquo;s employment under the provisions so indicated; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The applicable Termination Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8 <U>Termination Date</U>.
The Executive&rsquo;s Termination Date shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Executive&rsquo;s employment hereunder terminates on account of the Executive&rsquo;s death, the date of the Executive&rsquo;s death;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Executive&rsquo;s employment hereunder is terminated on account of the Executive&rsquo;s Disability, the date that it is determined that the Executive has a Disability;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Corporation terminates the Executive&rsquo;s employment hereunder for Cause, the date the Notice of Termination is delivered to the Executive;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Corporation terminates the Executive&rsquo;s employment hereunder without Cause, the date specified in the Notice of Termination, which shall be no less than 30 calendar days following the date on which the Notice of Termination is delivered; provided that, the Corporation shall have the option to provide the Executive with a lump sum payment equal to 30 calendar days&rsquo; Base Salary in lieu of such notice, which shall be paid in a lump sum on the Executive&rsquo;s Termination Date and for all purposes of this Agreement, the Executive&rsquo;s Termination Date shall be the date on which such Notice of Termination is delivered; and</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 24px; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Executive terminates his employment hereunder with or without Good Reason, the date specified in the Executive&rsquo;s Notice of Termination, which shall be no less than 30 calendar days following the date on which the Notice of Termination is delivered.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding anything contained herein, the
Termination Date shall not occur until the date on which the Executive incurs a Separation from Service within the meaning of Section
409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9&nbsp;&nbsp; <U>Resignation From Boards
and Committees</U>. Upon or promptly following any termination of Executive&rsquo;s employment with the Corporation, the Executive agrees
to resign, as of the date of such termination, from (i) each and every board of directors (or similar body, as the case may be) of the
Corporation and each of its affiliates on which the Executive may then serve, including, but not limited to, the Board (and any committees
thereof), and (ii) each and every office of the Corporation and each of its affiliates that the Executive may then hold, and all positions
that he may have previously held with the Corporation and any of its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10&nbsp; <U>Section 409A of the
Internal Revenue Code.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) This Agreement is intended
to comply with Section 409A of the Internal Revenue Code of 1986 (&ldquo;<U>Section 409A</U>&rdquo;) and shall be construed and interpreted
consistent with that intent. In the event that any payment or benefit payable under <I>Section 5</I> of this Agreement is not compliant
with Section 409A and any taxes, penalties or interest are imposed on the Executive under Section 409A as a result of such noncompliance
(the &ldquo;<U>Section 409A Penalties</U>&rdquo;), the Corporation shall put the Executive in an after tax economic position equivalent
to the position the Executive would have been in without the imposition of such Section 409A Penalties. The Executive shall notify the
Corporation in writing of any claim by the Internal Revenue Service or state tax authorities that, if successful, would require the payment
of any such Section 409A Penalties or related state tax statutes. The Executive&rsquo;s right to be put in an equivalent after tax economic
position is subject to the Executive providing such notification no later than ten (10) business days after Executive is informed in writing
of such claim. If the Corporation desires to contest such claim, Executive shall (i) cooperate with the Corporation in good faith in order
to effectively contest such claim and (ii) permit the Corporation to participate in any proceedings relating to such claim. The Corporation
shall control all proceedings taken in connection with such contest; provided, however, that the Corporation shall bear and pay directly
all costs and expenses (including additional interest and penalties) incurred in connection with such contest. This section shall also
apply to any taxes, penalties, or interest imposed by any state that are calculated in a manner similar to taxes, penalties, or interest
imposed by Section 409A(a)(1)(B), including those amounts imposed by the California Revenue and Taxation Code (R&amp;TC) Sections 17501
and 24601.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) If and to the extent that
any payment or benefit under this Agreement, or any plan or arrangement of the Corporation, is determined by the Corporation to constitute
&ldquo;non-qualified deferred compensation&rdquo; subject to Section 409A and is payable to the Executive by reason of the Executive&rsquo;s
termination of employment, then (a) such payment or benefit shall be made or provided to the Executive only upon a &ldquo;separation from
service&rdquo; as defined for purposes of Section 409A under applicable regulations (a &ldquo;<U>Separation from Service</U>&rdquo;) and
(b) if the Executive is a &ldquo;specified employee&rdquo; (within the meaning of Section 409A and as determined by the Corporation),
such payment or benefit shall not be made or provided before the date that is six (6) months after the date of the Executive&rsquo;s Separation
from Service (or the Executive&rsquo;s earlier death). For the purposes of clarity, the first payment thereof will include a catch-up
payment covering the amount that would have otherwise been paid to the Executive during the period between the termination of Executive&rsquo;s
employment and the first payment date but for the application of this provision, and the balance of the installments (if any) will be
payable in accordance with their original schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) To the extent any expense
reimbursement or in-kind benefit is determined to be subject to Section 409A, the amount of any such expenses eligible for reimbursement
or in-kind benefits provided in one taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits provided
in any other taxable year (except under any lifetime limit applicable to expenses for medical care), in no event shall any expenses be
reimbursed after the last day of the calendar year following the calendar year in which the Executive incurred such expenses, and in no
event shall any right to reimbursement or in-kind benefits be subject to liquidation or exchange for another benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) To the extent that any
provision of this Agreement is ambiguous as to its compliance with Section 409A, the provision will be read in such a manner so that all
payments hereunder comply with Section 409A. To the extent any payment under this Agreement may be classified as a &ldquo;short-term deferral&rdquo;
within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from
Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for
purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6. <U>Non-Competition</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt">The Executive acknowledges
and recognizes the highly competitive nature of the businesses of the Corporation, the amount of sensitive and confidential information
involved in the discharge of the Executive&rsquo;s position with the Corporation, and the harm to the Corporation that would result if
such knowledge or expertise was disclosed or made available to a competitor. Based on that understanding, the Executive hereby expressly
agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) As a result of the particular
nature of the Executive&rsquo;s relationship with the Corporation, in the capacities identified earlier in this Agreement, for the Term
of Employment, the Executive hereby agrees that he will not, directly or indirectly, (i) engage in any business for the Executive&rsquo;s
own account or otherwise derive any personal benefit from any business that competes with the business of the Corporation or any of its
affiliates (the Corporation and its affiliates are referred to, collectively, as the &ldquo;<U>Company Group</U>&rdquo;), (ii) enter the
employ of, or render any services to, any person engaged in any business that competes with the business of any entity within the Company
Group, (iii) acquire a financial interest in any person engaged in any business that competes with the business of any entity within the
Company Group, directly or indirectly, as an individual, partner, member, shareholder, officer, director, principal, agent, trustee or
consultant, or (iv) interfere with business relationships (whether formed before or after the Effective Date) between the Corporation,
any of its respective affiliates or subsidiaries, and any customers, suppliers, officers, employees, partners, members or investors of
any entity within the Company Group. For purposes of this Agreement, businesses in competition with the Company Group shall include, without
limitation, businesses which any entity within the Company Group may conduct operations, and any businesses which any entity within the
Company Group has specific plans to conduct operations in the future and as to which the Executive is aware of such planning, whether
or not such businesses have or have not as of that date commenced operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Notwithstanding anything
to the contrary in this Agreement, the Executive may, directly or indirectly, own, solely as an investment, securities of any Person,
other than a business that competes with the business of the Company Group, which are publicly traded on a national or regional stock
exchange or on the over-the-counter market if the Executive (i) is not a controlling Person of, or a member of a group that controls,
such Person, and (ii) does not, directly or indirectly, beneficially own one percent (1%) or more of any class of securities of such Person.
Executive may indirectly, through a mutual or exchange traded fund, own, solely as an investment, securities of a business that competes
with the business of the Company Group, which are publicly traded on a national or regional stock exchange or on the over-the-counter
market if the Executive (i) is not a controlling Person of, or a member of a group that controls, such Person, and (ii) does not, directly
or indirectly, beneficially own one percent (1%) or more of any class of securities of such business. For purposes of this <I>Section
6(b)</I>, &ldquo;<U>Person</U>&rdquo; shall have the meaning ascribed to such terms in Section 3(a)(9) of the Exchange Act and used in
Sections 13(d) and 14(d) thereof, including a &ldquo;group&rdquo; as described in Section 13(d) thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7. <U>Confidential Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a material part of the
consideration for the Corporation&rsquo;s commitment to the terms of this Agreement, the Executive hereby agrees that the Executive will
not at any time (whether during or after the Executive&rsquo;s employment with the Corporation), other than in the course of the Executive&rsquo;s
duties hereunder, or unless compelled by lawful process after written notice to the Corporation of such notice along with sufficient time
for the Corporation to try and overturn such lawful process, disclose or use for the Executive&rsquo;s own benefit or purposes or the
benefit or purposes of any other person, firm, partnership, joint venture, association, corporation or other business organization, entity
or enterprise, any trade secrets, or other confidential data or information relating to customers, development programs, costs, marketing,
trading, investment, sales activities, promotion, credit and financial data, financing methods, or plans of any entity within the Company
Group; <U>provided</U>, <U>however</U>, that the foregoing shall not apply to information which is generally known to the industry or
the public, other than as a result of the Executive&rsquo;s breach of this covenant. The Executive further agrees that the Executive will
not retain or use for his own account, at any time, any trade names, trademark or other proprietary business designation used or owned
in connection with the business of any entity within the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8. <U>Proprietary Rights</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Inventions</U>. All
inventions, policies, systems, developments or improvements conceived, designed, implemented and/or made by the Executive, either alone
or in conjunction with others, at any time or at any place during the Term of Employment, whether or not reduced to writing or practice
during such Term of Employment, which directly or indirectly relate to the business of any entity within the Company Group, or which were
developed or made in whole or in part using the facilities and/or capital of any entity within the Company Group, shall be the sole and
exclusive property of the Company Group. The Executive shall promptly give notice to the Corporation of any such invention, development,
patent or improvement, and shall at the same time, without the need for any request by any person or entity within the Company Group,
assign all of the Executive&rsquo;s rights to such invention, development, patent and/or improvement to the Company Group. The Executive
shall sign all instruments necessary for the filing and prosecution of any applications for, or extensions or renewals of, letters patent
of the United States or any foreign country that any entity in the Company Group desires to file.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Work Product</U>. The
Executive acknowledges and agrees that all writings, works of authorship, technology, inventions, discoveries, ideas and other work product
of any nature whatsoever, that are created, prepared, produced, authored, edited, amended, conceived or reduced to practice by the Executive
individually or jointly with others during the Term of the Executive&rsquo;s employment by the Corporation and relating in any way to
the business or contemplated business, research or development of the Corporation (regardless of when or where the Work Product is prepared
or whose equipment or other resources is used in preparing the same) and all printed, physical and electronic copies, all improvements,
rights and claims related to the foregoing, and other tangible embodiments thereof (collectively, &ldquo;<U>Work Product</U>&rdquo;),
as well as any and all rights in and to copyrights, trade secrets, trademarks (and related goodwill), patents and other intellectual property
rights therein arising in any jurisdiction throughout the world and all related rights of priority under international conventions with
respect thereto, including all pending and future applications and registrations therefor, and continuations, divisions, continuations-in-part,
reissues, extensions and renewals thereof (collectively, &ldquo;<U>Intellectual Property Rights</U>&rdquo;), shall be the sole and exclusive
property of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement,
Work Product includes, but is not limited to, Company Group information, including plans, publications, research, strategies, techniques,
agreements, documents, contracts, terms of agreements, negotiations, know-how, computer programs, computer applications, software design,
web design, work in process, databases, manuals, results, developments, reports, graphics, drawings, sketches, market studies, formulae,
notes, communications, algorithms, product plans, product designs, styles, models, audiovisual programs, inventions, unpublished patent
applications, original works of authorship, discoveries, experimental processes, experimental results, specifications, customer information,
client information, customer lists, client lists, manufacturing information, marketing information, advertising information, and sales
information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Work Made for Hire;
Assignment</U>. All copyrightable work by the Executive during the Term of Employment that relates to the business of any entity in the
Company Group is intended to be &ldquo;work made for hire&rdquo; as defined in Section 101 of the Copyright Act of 1976, and shall be
the property of the Company Group. If the copyright to any such copyrightable work is not the property of the Company Group by operation
of the law, the Executive will, without further consideration, assign to the Company Group all right, title and interest in such copyrightable
work and will assist the entities in the Company Group and their nominees in every way, at the Company Group&rsquo;s expense, to secure,
maintain and defend for the Company Group&rsquo;s benefit, copyrights and any extensions and renewals thereof on any and all such work
including translations thereof in any and all countries, such work to be and to remain the property of the Company Group whether copyrighted
or not.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Further Assurances;
Power of Attorney</U>. During and after the Executive&rsquo;s employment, the Executive agrees to reasonably cooperate with the Corporation
to (i) apply for, obtain, perfect and transfer to the Company Group the Work Product as well as an Intellectual Property Right in the
Work Product in any jurisdiction in the world; and (ii) maintain, protect and enforce the same, including, without limitation, executing
and delivering to the Corporation any and all applications, oaths, declarations, affidavits, waivers, assignments and other documents
and instruments as shall be requested by the Corporation. The Executive hereby irrevocably grants the Corporation power of attorney to
execute and deliver any such documents on the Executive&rsquo;s behalf in the Executive&rsquo;s name and to do all other lawfully permitted
acts to transfer the Work Product to the Corporation and further the transfer, issuance, prosecution and maintenance of all Intellectual
Property Rights therein, to the full extent permitted by law, if the Executive does not promptly cooperate with the Corporation&rsquo;s
request (without limiting the rights the Corporation shall have in such circumstances by operation of law). The power of attorney is coupled
with an interest and shall not be effected by the Executive&rsquo;s subsequent incapacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>No License</U>. The
Executive understands that this Agreement does not, and shall not be construed to, grant the Executive any license or right of any nature
with respect to any Work Product or Intellectual Property Rights or any Confidential Information, materials, software or other tools made
available to the Executive by the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9. <U>Anti-Solicitation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of the amount of
sensitive and confidential information involved in the discharge of the Executive&rsquo;s duties, and the harm to the Corporation that
would result if such knowledge or expertise were disclosed or made available to a competitor, and as a reasonable step to help protect
the confidentiality of such information, the Executive promises and agrees that during the Term of Employment and for a period of two
(2) years thereafter, the Executive will not use the Company&rsquo;s confidential information to, directly or indirectly, individually
or as a consultant to, or as an employee, officer, shareholder, director or other owner or participant in any business, influence or attempt
to influence the customers, vendors, suppliers, joint venturers, associates, consultants, agents, or partners of any entity within the
Company Group, either directly or indirectly, to divert their business away from the Company Group, to any individual, partnership, firm,
corporation or other entity then in competition with the business of any entity within the Company Group, and he will not otherwise materially
interfere with any business relationship of any entity within the Company Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10. <U>Non-Solicitation of Employees</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In light of the amount of
sensitive and confidential information involved in the discharge of the Executive&rsquo;s duties, and the harm to the Corporation that
would result if such knowledge or expertise were disclosed or made available to a competitor, and as a reasonable step to help protect
the confidentiality of such information, the Executive promises and agrees that during the Term of Employment and for a period of one
(1) year thereafter, the Executive will not, directly or indirectly, individually or as a consultant to, or as an employee, officer, shareholder,
director, or other owner of or participant in any business, solicit (or assist in soliciting) any person who is then, or at any time within
six (6) months prior thereto was, an employee of an entity within the Company Group, who earned annually $25,000 or more as an employee
of such entity during the last six (6) months of his or her own employment to work for (as an employee, consultant or otherwise) any business,
individual, partnership, firm, corporation, or other entity whether or not engaged in competitive business with any entity in the Company
Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11. <U>Non-Disparagement</U>. The Executive agrees
and covenants that the Executive shall not at any time make, publish, or communicate to any person or entity or in any public forum any
defamatory, or maliciously false, or disparaging remarks, comments, or statements concerning the Company Group or its businesses, or any
of its employees, officers, or directors and their existing and prospective customers, suppliers, investors, and other associated third
parties, now or in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12. <U>Return of Property</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Executive agrees to truthfully
and faithfully account for and deliver to the Corporation all property belonging to the Corporation, any other entity in the Company Group,
or any of their respective affiliates, which the Executive may receive from or on account of the Corporation, any other entity in the
Company Group, or any of their respective affiliates, and upon the termination of the Term of Employment, or the Corporation&rsquo;s demand,
the Executive shall immediately deliver to the Corporation all such property belonging to the Corporation, any other entity in the Company
Group, or any of their respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13. <U>Withholding Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything else
herein to the contrary, the Corporation may withhold (or cause there to be withheld, as the case may be) from any amounts otherwise due
or payable under or pursuant to this Agreement such federal, state and local income, employment, or other taxes as may be required to
be withheld pursuant to any applicable law or regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. <U>Cooperation in Litigation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Executive agrees that,
during the Term of Employment or after the termination of the Executive&rsquo;s employment, he will reasonably cooperate with the Corporation,
subject to his reasonable personal and business schedules, in any litigation which arises out of events occurring prior to the termination
of his employment, including but not limited to, serving as a witness or consultant and producing documents and information relevant to
the case or helpful to the Corporation. The Corporation agrees to reimburse the Executive for all reasonable costs and expenses he incurs
in connection with his obligations under this <I>Section 14</I> and, in addition, to reasonably compensate the Executive for time actually
spent in connection therewith following the termination of his employment with the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15. <U>Miscellaneous</U>.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Assignment</U>. This Agreement is personal
in its nature and neither of the parties hereto shall, without the consent of the other, assign or transfer this Agreement or any rights
or obligations hereunder; <U>provided</U>, <U>however</U>, that in the event of a merger, consolidation, or transfer or sale of all or
substantially all of the assets of the Corporation with or to any other individual(s) or entity, this Agreement shall, subject to the
provisions hereof, be binding upon and inure to the benefit of such successor and such successor shall discharge and perform all the promises,
covenants, duties, and obligations of the Corporation hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Number and Gender</U>. Where the context
requires, the singular shall include the plural, the plural shall include the singular, and any gender shall include all other genders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Section Headings</U>. The section headings
of, and titles of paragraphs and subparagraphs contained in, this Agreement are for the purposes of convenience only, and they neither
form a part of this Agreement nor are they to be used in the construction or interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Governing Law</U>. This Agreement, and
all questions relating to its validity, interpretation, performance and enforcement, as well as the legal relations hereby created between
the parties hereto, shall be governed by and construed under, and interpreted and enforced in accordance with, the laws of the State of
California, notwithstanding any California or other conflict of law provision to the contrary. This Agreement is intended to comply with
Section 409A of the Internal Revenue Code of 1986 and the regulations promulgated thereunder. Any action or proceeding by either of the
parties to enforce this Agreement shall be brought only in a state or federal court located in the state of California, Sonoma county.
The parties hereby irrevocably submit to the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the
maintenance of any such action or proceeding in such venue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Severability</U>. If any provision of this
Agreement or the application thereof is held invalid, the invalidity shall not affect other provisions or applications of this Agreement
which can be given effect without the invalid provisions or applications and to this end the provisions of this Agreement are declared
to be severable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Entire Agreement</U>. This Agreement replaces
and supersedes prior employment agreements, including the employment agreement executed by and between the Executive and the Corporation
dated January 1, 2004, June 20, 2013, and November 30, 2016. This Agreement embodies the entire agreement of the parties hereto respecting
the matters within its scope. Any prior negotiations, correspondence, agreements, proposals or understandings relating to the subject
matter hereof shall be deemed to have been merged into this Agreement, and to the extent inconsistent herewith, such negotiations, correspondence,
agreements, proposals, or understandings shall be deemed to be of no force or effect. There are no representations, warranties, or agreements,
whether express or implied, or oral or written, with respect to the subject matter hereof, except as expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Modifications</U>. This Agreement may not
be amended, modified or changed (in whole or in part), except by a formal definitive written agreement expressly referring to this Agreement,
which agreement is executed by both of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Waiver</U>. Neither the failure nor any
delay on the part of a party to exercise any right, remedy, power or privilege under this Agreement shall operate as a waiver thereof,
nor shall any single or partial exercise of any right, remedy, power or privilege preclude any other or further exercise of the same or
of any right, remedy, power or privilege, nor shall any waiver of any right, remedy, power or privilege with respect to any occurrence
be construed as a waiver of such right, remedy, power or privilege with respect to any other occurrence. No waiver shall be effective
unless it is in writing and is signed by the party asserted to have granted such waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) <U>Resolution of Disputes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i) Any controversy arising
out of or relating to the Executive&rsquo;s employment (whether or not before or after the expiration of the Term of Employment), any
termination of the Executive&rsquo;s employment, this Agreement or the enforcement or interpretation of this Agreement, or because of
an alleged breach, default, or misrepresentation in connection with any of the provisions of this Agreement, including (without limitation)
any state or federal statutory claims, shall be submitted to arbitration in California, before a sole arbitrator (the &ldquo;<U>Arbitrator</U>&rdquo;)
selected from the American Arbitration Association (&ldquo;<U>AAA</U>&rdquo;), and shall be conducted in accordance with the provisions
of California Code of Civil Procedure &sect;&sect; 1280 <U>et seq</U>. as the exclusive remedy of such dispute; <U>provided</U>, <U>however</U>,
that provisional injunctive relief may, but need not, be sought in a court of law while arbitration proceedings are pending, and any provisional
injunctive relief granted by such court shall remain effective until the matter is finally determined by the Arbitrator. Final resolution
of any dispute through arbitration may include any remedy or relief that the Arbitrator deems just and equitable, including any and all
remedies provided by applicable state or federal statutes. At the conclusion of the arbitration, the Arbitrator shall issue a written
decision that sets forth the essential findings and conclusions upon which the Arbitrator&rsquo;s award or decision is based. Any award
or relief granted by the Arbitrator hereunder shall be final and binding on the parties hereto and may be enforced by any court of competent
jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii) The parties acknowledge
and agree that they are hereby waiving any rights to trial by jury in any action, proceeding or counterclaim brought by either of the
parties against the other in connection with any matter whatsoever arising out of or in any way connected with any of the matters referenced
in the first sentence of <I>Section 15(i)(i)</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iii) The parties agree that
the Corporation shall be responsible for payment of the forum costs of any arbitration hereunder, including the Arbitrator&rsquo;s fee.
The parties further agree that in any proceeding with respect to such matters, the prevailing party will be entitled to recover its reasonable
attorney&rsquo;s fees and costs from the non-prevailing party (other than forum costs associated with the arbitration which in any event
shall be paid by the Corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(iv) Without limiting the
remedies available to the parties and notwithstanding the foregoing provisions of this <I>Section 15</I>, the Executive and the Corporation
acknowledge that any breach of any of the covenants or provisions contained in <I>Sections 5.9</I>, and <I>Sections 6</I> through <I>11</I>
could result in irreparable injury to either of the parties hereto for which there might be no adequate remedy at law, and that, in the
event of such a breach or threat thereof, the non-breaching party shall be entitled to obtain a temporary restraining order and/or a preliminary
injunction and a permanent injunction restraining the other party hereto from engaging in any activities prohibited by any covenant or
provision in <I>Sections 5.9</I>, and <I>Sections 6</I> through <I>11</I> or such other equitable relief as may be required to enforce
specifically any of the covenants or provisions of <I>Sections 5.9</I>, and <I>Sections 6</I> through <I>11</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) <U>Publicity</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">The Executive hereby irrevocably
consents during the term of this Agreement to any and all uses and displays, by the Company Group and its agents, representatives and
licensees, of the Executive&rsquo;s name, voice, likeness, image, appearance and biographical information in, on or in connection with
any pictures, photographs, audio and video recordings, digital images, websites, television programs and advertising, other advertising
and publicity, sales and marketing brochures, books, magazines, other publications, CDs, DVDs, tapes and all other printed and electronic
forms and media throughout the world, at any time during or after the period of his employment by the Company, for all legitimate commercial
and business purposes of the Company Group (&ldquo;<U>Permitted Uses</U>&rdquo;) without further consent from or royalty, payment or other
compensation to the Executive. The Executive hereby forever waives and releases the Company Group and its directors, officers, employees
and agents from any and all claims, actions, damages, losses, costs, expenses and liability of any kind, arising under any legal or equitable
theory whatsoever at any time during or after the period of his employment by the Company, arising directly or indirectly from the Company
Group&rsquo;s and its agents&rsquo;, representatives&rsquo; and licensees&rsquo; exercise of their rights in connection with any Permitted
Uses. At the end of the term of this Agreement, the Company shall have no obligation to remove any previously-published displays described
in this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) <U>Notices</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(i) All notices, requests,
demands and other communications required or permitted under this Agreement shall be in writing and shall be deemed to have been duly
received if (i) delivered by hand or by courier, effective upon delivery, (ii) given by facsimile or electronic version, when transmitted
if transmitted on a business day and during normal business hours of the recipient, and otherwise delivered on the next business day following
transmission, or (iii) sent by registered or certified mail, postage prepaid, return receipt requested, 5 business days after being deposited
in the U.S. postal mail. Any notice shall be duly addressed to the parties as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(i) If to the Corporation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Sonoma Pharmaceuticals, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Lead Independent Director<BR>
645 Molly Lane, Suite 150<BR>
Woodstock, GA 30189<BR>
&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(ii) If to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Bruce Thornton<BR>
At the address on file with the Corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 60pt">(ii) Any party may alter the
address to which communications or copies are to be sent by giving notice of such change of address in conformity with the provisions
of this Section 15 for the giving of notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l) <U>Legal Counsel; Mutual Drafting</U>. Each
party recognizes that this is a legally binding contract and acknowledges and agrees that they have had the opportunity to consult with
legal counsel of their choice. Each party has cooperated in the drafting, negotiation and preparation of this Agreement. Hence, in any
construction to be made of this Agreement, the same shall not be construed against either party on the basis of that party being the drafter
of such language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) <U>Provisions that Survive Termination</U>.
The provisions of <I>Sections 3.4</I>, <I>3.5</I>, <I>5</I> through <I>11</I>, 14 and this <I>Section 15</I> shall survive any termination
of the Term of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) <U>Counterparts</U>. This Agreement may be
executed in any number of counterparts, each of which shall be deemed an original as against any party whose signature appears thereon,
and all of which together shall constitute one and the same instrument. This Agreement shall become binding when one or more counterparts
hereof, individually or taken together, shall bear the signatures of all of the parties reflected hereon as the signatories. Photographic
copies of such signed counterparts may be used in lieu of the originals for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <U>Tolling</U>. Should the Executive violate
any of the terms of the restrictive covenant obligations articulated herein, the obligation at issue will run from the first date on which
the Executive ceases to be in violation of such obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page Follows]<BR STYLE="clear: both">
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the Corporation and
the Executive have executed this Amended and Restated Employment Agreement as of the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATION</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonoma Pharmaceuticals, Inc.,</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware corporation</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 52%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 43%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jerry McLaughlin</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title:</P></TD>
    <TD STYLE="vertical-align: top; border-top: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jerry McLaughlin<BR>
Chairman of the Compensation Committee</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Bruce Thornton</FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Thornton</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT A &mdash; RELEASE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1. <U>Definitions</U>. I intend
all words used in this Release to have their plain meanings in ordinary English. Technical legal words are not needed to describe what
I mean. Specific terms I use in this Release have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. &ldquo;I,&rdquo; &ldquo;me,&rdquo;
and &ldquo;my&rdquo; include me, Bruce Thornton, and anyone who has or obtains any legal rights or claims through me, including my heirs
and estate, and each of my descendants, dependents, executors, administrators, assigns and successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. &ldquo;Employer,&rdquo;
as used in this Release, shall at all times mean Oculus Innovative Sciences, Inc. and &ldquo;Released Party&rdquo; or &ldquo;Released
Parties&rdquo;, individual and collectively, means the Employer and the Employer&rsquo;s parent, past or present subsidiaries, affiliates,
each of any present or former officers, directors, shareholders, employees, agents or attorneys, trustees, insurers, successors, predecessors,
assigns, or personal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. &ldquo;My Claims&rdquo;
mean actions or causes of action, suits, claims, charges, complaints, contracts (whether oral or written, express or implied from any
source), and promises, whatsoever, in law or equity, that I ever had, may now have or hereafter can, shall or may have against the Employer
or other Released Party as of the date of the execution of this Release, including all unknown, undisclosed and unanticipated losses,
wrongs, injuries, debts, claims or damages to me for, upon, or by reason of any matter, cause or thing whatsoever, that are in any way
related to my employment with or separation (termination of employment) from the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing this Release, I
am agreeing to release any actual and potential claim, known or unknown, I have or may potentially have, in law or in equity, either as
an individual or standing in the shoes of the government, under any federal, state or local law, administrative regulation or legal principle
(except as provided in Paragraph 4 of this Release). The following listing of laws and types of claims is not meant to, and shall not
be interpreted to, exclude any particular law or type of claim, law, regulation or legal principle not listed. I understand I am releasing
all my Claims, including, but not limited to, claims for invasion of privacy; breach of written or oral, express or implied, contract;
fraud or misrepresentation; and any claim under Section 1981 of the Civil Rights Act of 1866, Title VII of the Civil Rights Act of 1964,
Age Discrimination in Employment Act of 1967 (&ldquo;ADEA&rdquo;), 29 U.S.C. &sect; 626, as amended, the Older Workers Benefit Protection
Act of 1990 (&ldquo;OWBPA&rdquo;), 29 U.S.C. 626(f), Title VII of the Civil Rights Act of 1964 (&ldquo;Title VII&rdquo;), 42 U.S.C. &sect;
2000e, et seq., the Americans with Disabilities Act Amendments Act (&ldquo;ADAAA&rdquo;), 29 U.S.C. &sect; 2101, et seq., the Family and
Medical Leave Act (&ldquo;FMLA&rdquo;), 29 U.S.C. &sect; 2601 et seq., the Employee Retirement Income Security Act of 1974 (&ldquo;ERISA&rdquo;),
as amended, 29 U.S.C. &sect;&sect; 1001, et seq., Equal Pay Act (&ldquo;EPA&rdquo;), 29 U.S.C. &sect; 206(d), the Worker Adjustment and
Retraining Notification Act (&ldquo;WARN&rdquo;), 29 U.S.C. &sect; 2101 et seq., the False Claims Act, 31 U.S.C. &sect; 3729 et seq.,
the California Fair Employment and Housing Act, the California Family Rights Act, any other state human rights or fair employment practices
act, and any other federal, state, or local statute, law, rule, regulation, ordinance or order. This includes, but is not limited to,
claims for violation of any civil rights laws based on protected class status; claims for assault, battery, defamation, intentional or
negligent infliction of emotional distress, breach of the covenant of good faith and fair dealing, promissory estoppel, negligence, negligent
hiring, retention or supervision, retaliation, constructive discharge, violation of whistleblower protection laws, unjust enrichment,
payment of any kind, including any other claim for severance pay, bonus or incentive pay, sick leave, holiday pay, vacation pay, life
insurance, health or medical insurance or any other fringe benefit, medical expenses, or disability, violation of public policy, and all
other claims for unlawful employment practices, and all other common law or statutory claims. To the maximum extent permitted by law,
I agree that I will not seek and waive any right to accept any relief or award from any charge or action against the Employer before any
federal, state, or local administrative agency or federal state or local court whether filed by me or on my behalf with respect to any
claim or right covered by this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Agreement to Release
My Claims</U>. Except as stated in Paragraph 4, I agree to give up all My Claims, waive any rights thereunder, and forever discharge the
Employer and all Released Parties of and from any and all liability to me for actions or causes of action, suits, or Claims. To the maximum
extent permitted by law, I agree that I will not seek and I waive any right to accept any relief or award from any charge or action against
the Employer or other Released Party before any federal, state, or local administrative agency or federal state or local court whether
filed by me or on my behalf with respect to any claim or right covered by this Release. I also agree to withdraw any and all of my charges
and lawsuits against Employer or other Released Party, except that I may, but am not required to, withdraw or dismiss, or attempt to withdraw
or dismiss, any charges that I may have pending against the Employer or other Released Party with the EEOC or other civil rights enforcement
agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I represent and warrant that
I have not transferred or otherwise assigned my Claims, or parts thereof, to any person or entity, other than the Employer. I will defend,
indemnify and hold harmless the Employer from and against any claim (including the payment of attorneys&rsquo; fees and costs actually
incurred whether or not litigation is commenced) that is directly or indirectly based on or in connection with or arising out of any such
assignment or transfer made, purported or claimed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;In exchange for my agreement
to release my Claims, I am receiving satisfactory Consideration (compensation) from the Employer to which I am not otherwise entitled
by law, contract, or under any Employer policy. The consideration I am receiving is a full and fair payment for the release of all my
Claims. The Employer and the Released Parties do not owe me anything in addition to what I will be receiving.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Older Workers Benefit
Protection Act</U>. [This section may be revised if Executive terminates employment as part of a &ldquo;group&rdquo; termination.] The
Older Workers Benefit Protection Act (&ldquo;OWBPA&rdquo;) applies to individuals age 40 and older and sets forth certain criteria for
such individuals to waive their rights under the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;) in connection with an exit
incentive program or other employment termination program. I understand and have been advised that this Release of My Claims is subject
to the terms of the OWBPA. The OWBPA provides that an individual cannot waive a right or claim under the ADEA unless the waiver is knowing
and voluntary. I have been advised of this law, and I agree that I am signing this Release voluntarily, and with full knowledge of its
consequences. I understand that the Employer is giving me at least twenty-one (21) calendar days from the date I received a copy of this
Release to decide whether I want to sign it. I acknowledge that I have been advised to use this time to consult with an attorney about
the effect of this Release. If I sign this Release before the end of the twenty-one (21) day period it will be my personal, voluntary
decision to do so, and will be done with full knowledge of my legal rights. I agree that material and/or immaterial changes to the Separation
Agreement or this Release will not restart the running of this consideration period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4. <U>Exclusions from Release</U>.
My Claims do not include my rights, if any, to claim the following: unemployment insurance or workers compensation benefits; claims for
my vested post-termination benefits under any 401(k) or similar tax-qualified retirement benefit plan; my COBRA rights; and my rights
to enforce the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. Nothing in this Release
interferes with my right to file a charge with the Equal Employment Opportunity Commission (&ldquo;EEOC&rdquo;) or other local civil rights
enforcement agency, or participate in any manner in an EEOC investigation or proceeding under Title VII, the ADA, the ADEA, or the EPA.
I, however, understand that I am waiving my right to recover individual relief including, but not limited to, back pay, front pay, reinstatement,
attorneys&rsquo; fees, and/or punitive damages, in any administrative or legal action whether brought by the EEOC or other civil rights
enforcement agency, me or any other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. Nothing in this Release
interferes with my right to challenge the knowing and voluntary nature of this Release under the ADEA and/or OWBPA, if I have rights under
such laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. I agree that the Employer
and the Released Parties reserve any and all defenses, which any of them has or might have against any claims brought by me. This includes,
but is not limited to, the Employer&rsquo;s or other Released Party&rsquo;s right to seek available costs and attorneys&rsquo; fees, and
to have any monetary award granted to me, if any, reduced by the amount of money that I received in consideration for this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. Nothing in this Release
releases any claims for indemnification by Executive pursuant to any indemnification agreement, statute or otherwise or claims for coverage
under any D&amp;O or other similar insurance policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5. <U>Effective Date; Right
to Rescind or Revoke</U>. I understand that insofar as this Release relates to my rights under the Age Discrimination in Employment Act
(&ldquo;ADEA&rdquo;), it shall not become effective or enforceable until seven (7) calendar days after I sign it. I also have the right
to rescind (or revoke) this Release insofar as it extends to potential claims under the ADEA by written notice to Employer within seven
(7) calendar days following my signing this Release (the &ldquo;Rescission Period&rdquo;). Any such rescission (or revocation) must be
in writing and hand-delivered to Employer or, if sent by mail, postmarked within the applicable time period, sent by certified mail, return
receipt requested, and addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. post-marked within the
seven (7) calendar day Rescission Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. properly addressed to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">[INSERT NAME AND ADDRESS];
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. sent by certified mail,
return receipt requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6. <U>I Understand the Terms
of this Release</U>. I have had the opportunity to read this Release carefully and understand all its terms. I have had the opportunity
to review this Release with my own attorney. In agreeing to sign this Release, I have not relied on any statements or explanations made
by the Employer or its attorneys. I understand and agree that this Release and the attached Agreement contain all the agreements between
the Employer (and any other Released Party) and me. We have no other written or oral agreements. I understand this Release is a very important
legal document and I agree to be bound by the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD>
    <TD STYLE="width: 62%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: ____________, 20__</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Thornton</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>snoa-20220722.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa6MqaPty552+YkxvmR/fSl67yYh6kj1kSrMfCRWoWsI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:SNOA="http://sonomapharma.com/20220722" elementFormDefault="qualified" targetNamespace="http://sonomapharma.com/20220722">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sonomapharma.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="snoa-20220722_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="snoa-20220722_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>snoa-20220722_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>snoa-20220722_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sonomapharma.com/role/Cover" xlink:href="snoa-20220722.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sonomapharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm140193621549808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 22, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 22,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SONOMA
PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001367083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0423298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">645 Molly Lane<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woodstock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">759-9305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNOA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>snoa_i8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snoa-20220722.xsd" xlink:type="simple"/>
    <context id="From2022-07-22to2022-07-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001367083</identifier>
        </entity>
        <period>
            <startDate>2022-07-22</startDate>
            <endDate>2022-07-22</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-22to2022-07-22">0001367083</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-22to2022-07-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-07-22to2022-07-22">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-22to2022-07-22">2022-07-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-07-22to2022-07-22">SONOMA PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-22to2022-07-22">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-07-22to2022-07-22">001-33216</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-22to2022-07-22">68-0423298</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-22to2022-07-22">645 Molly Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-07-22to2022-07-22">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-22to2022-07-22">Woodstock</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-22to2022-07-22">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-22to2022-07-22">30189</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-22to2022-07-22">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-22to2022-07-22">759-9305</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-07-22to2022-07-22">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-07-22to2022-07-22">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-07-22to2022-07-22">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-07-22to2022-07-22">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-07-22to2022-07-22">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-22to2022-07-22">SNOA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-22to2022-07-22">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-22to2022-07-22">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( )2#]E0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "4@_94CNW3SNX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*'%@'2;UI:.G#@8K;.QF;+4UBQUC:R1]^R5>FS*V!]C1TN]/
MGT"M#D+W$9]C'S"2Q70WNLXGH<.:G8B" $CZA$ZE<DKXJ7GHHU,T/>,1@M(?
MZHC J^H>')(RBA3,P"(L1"9;HX6.J*B/%[S1"SY\QB[#C ;LT*&G!'59 Y/S
MQ' >NQ9N@!E&&%WZ+J!9B+GZ)S9W@%V28[)+:AB&<FAR;MJAAK>GW4M>M[ ^
MD?(:IU_)"CH'7+/KY-=F\[C?,LDKSHMJ57"^YY7@#Z)9O<^N/_QNPJXW]F#_
ML?%54+;PZR[D%U!+ P04    " "4@_94F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M )2#]E3B9R!%6 0   L1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AO<Z)($,;?[Z>8XJJN=JN2"./_G%I%C-GU-C%><"]5=W4O1AAU*L!PPQ#C
MM[\>-.#FL-$7R@#]\*.[>69PL)7J)=UPKLE;%,;IT-IHG5PW&JF_X1%+KV3"
M8SBRDBIB&H9JW4@3Q5F0!T5A@]IVIQ$Q$5NC0;YOKD8#F>E0Q'RN2)I%$5.[
M&Q[*[=!RK/<=3V*]T69'8S1(V)I[7/](Y@I&C4(E$!&/4R%CHOAJ:+G.]0UM
MFX#\C#\%WZ9'V\3<RE+*%S.8!D/+-D0\Y+XV$@Q^7OF8AZ%1 HY_#Z)6<4T3
M>+S]KGZ7WSS<S)*E?"S#9Q'HS=#J623@*Y:%^DENO_'##>6 O@S3_)ML]^>V
M6A;QLU3+Z! ,!)&(][_L[9"(HP#:/Q% #P$TY]Y?**>\99J-!DINB3)G@YK9
MR&\UCP8X$9NJ>%K!40%Q>C26KUP-&AJDS(Z&?PB[V8?1$V&_9^$5H?2"4)O2
MG\,;0%!@T *#YGI-#(/\[2Y3K:!0_U01[15:U0JF>Z_3A/E\:$%[IER]<FOT
MZR].Q_X-X6L6?$U,?70K_0QZ49/%+N%5<'AX[_([ M$J(%JHB@L$04YQ%[)U
M%04>OV)ARA&.=L'1/B\9<ZZ$#,@D#@@T7V5><*6BC>KZJ%.@=5#!2:R%WI$[
M$7(RRZ)E=6_C&K;M7#:;U.D@/-V"IWL.SQ-?"]/9D+,9BRH3A>MXC[/'!_?3
M_)O[].".)S\6T[%[[UV0Z6Q\A6#V"LS>.9AC**IB(9G& 7\CW_FN"A17LB%[
MS4[7[C41K'Z!U3\':\'>R#0 -K$2/LO-_'1M<<5.[])NT2;M]Q \QR[-TSX'
M<!K[4B52Y6P7Q-/P,!"IR%AFD%#(JPPJ:UZC?CO!((\<WCD'T@T"\,7TXGV#
MW,-YY#&N)L,E.ZTV>9!AN"/W[*/ SY3E!."@_HU3+K:RDA*7]#(!=7#:-@98
MS@ .[N$? <=F!$5>R&U<"8?+/4L9P.SNOV!PY<S@X-;^$:YHP;F2KR+VJXN,
M:WYU,;1RLG!PC_^(-I>I!H_Y2R2GGPM<L6D[O3[&5LX6#F[U>0U=6,V>1L$%
M/O=L^PN&4DX4#N[P]]*'K,PW,L9FKAJ1;KM_V6_:;8RHG!,<W,J?E=":QY":
M*,KB@_.FE52X4-VZPRGG P>W;T^&PA=:Q&OR  VN! LK>7"5.AY:^C_%'7JN
M^*4/Z>'PA.V7A[!"@X7LXVI57;\:O5JRTO0I[M#_(YNF:09DM8"X;"W@T8(?
M-^>%T+!&DROBT,_++\3C?@;]5KGBJ%$R_2GC3P0^7HVATM+M*6[/"\4"TV;>
M+EK*RB:K$?!FCYA_TM+:*6[#[YDADS=_P^(U/[F$K!&:N=ZM^P?&5'HZ/<O3
M)Q%7:Y.EKZ"@-\8I$A97UQ 7/-E7C:-76_,WP0,S5TQ)R%<@9%]U05?MW[SW
M RV3_&UW*36\.^>;&\Z@Y\T)<'PEI7X?F!?HXO^/T7]02P,$%     @ E(/V
M5)^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)J
MXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN
M6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9
MWMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+
ME)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64
M,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).
MIF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3
M"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^
MFO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA
M6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;
M^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.
MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
MQ1' L#P8 \PG>&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\
M3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4
MKS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0E<Q;M@)QI$\QQ"8Q?B,9AE2
MG0P^\?Y@IR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 10
M2P,$%     @ E(/V5)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#
M, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M
M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD
M%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3
MY?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^
M-8+)#^Q^ %!+ P04    " "4@_94JL0B%C,!   B @  #P   'AL+W=O<FMB
M;V]K+GAM;(U1T6[", S\E2H?L!:T(0U17D#;D*8-C8GWT+K4(HDKQX6-KY_;
MJAK27O:4W-FZW%T6%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q
M8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P.6/$ SJ4[]ST
M=P<F\1C0XQ7*W&0FB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7F?RTA]@S8@\?
M5HWD9I:I8(4<I=_H]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#B
MG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMRR"9JZJ8IGJ,.
M>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]0
M2P,$%     @ E(/V5"0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!
MD#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&
MO-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S"
M:+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X
M=/X!4$L#!!0    ( )2#]E1ED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP
M97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*
MH!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJU
MDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7
MQ<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!Z
MVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$
M?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q
M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ E(/V5 =!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M" "4@_94CNW3SNX    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    " "4@_94F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( )2#]E3B
M9R!%6 0   L1   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    " "4@_94GZ ;\+$"  #B#   #0
M    @ &;#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( )2#]E27BKL<P
M !,"   +              "  7</  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M )2#]E2JQ"(6,P$  "("   /              "  6 0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    " "4@_94)!Z;HJT   #X 0  &@
M@ ' $0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "4
M@_9499!YDAD!  #/ P  $P              @ &E$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  #O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="snoa_i8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sonomapharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="snoa_i8k.htm">snoa_i8k.htm</File>
    <File>snoa-20220722.xsd</File>
    <File>snoa-20220722_lab.xml</File>
    <File>snoa-20220722_pre.xml</File>
    <File>snoa_ex1001.htm</File>
    <File>snoa_ex1002.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "snoa_i8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "snoa_i8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "snoa-20220722_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "snoa-20220722_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "snoa-20220722.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SNOA",
   "nsuri": "http://sonomapharma.com/20220722",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "snoa_i8k.htm",
      "contextRef": "From2022-07-22to2022-07-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://sonomapharma.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "snoa_i8k.htm",
      "contextRef": "From2022-07-22to2022-07-22",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://sonomapharma.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001683168-22-005083-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-005083-xbrl.zip
M4$L#!!0    ( )2#]E2J/'.!*@,  +<+   1    <VYO82TR,#(R,#<R,BYX
M<V2U5=MRVC 0?6YG^@^J7SNR,"FD(9!,)FDZ3"')0'-[Z@A;!A59<B29R]]7
M\H4[%&CK)VGWG+.[TJY<OYQ$#(R(5%3PAN.Y)0<0[HN \G[#>>S"J^YUL^F
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MIRG--5U20*STCME*3W[U-/+ A026_IK*VNP;$1$3J:EIU84!SU*GVM(?%L(
M&T<Y /V+DAGN'5JRH1#V'VMM6?W%(O,A0?,IR?>KDU0WY0JI 5\;RUTO8_:F
MMX2?2NV@V!TL>-":H%>&)YX[4<$\TT.2F)_ 84D4O".2V/(^;XJOML'M(FVA
M?8-N>>=W!MW(081I55B.3F'QK_ 7.:0R!R6Q=)V!ELA*6-$2+'FP[&U/YT_,
M=*^.:@)?)%S+Z2&-L$@I-L?=QOQ_OM]%%/CL$NPO_MBP1W3!>O!-+5!'F9I9
M_@902P,$%     @ E(/V5'*4Y-[^"@  @(8  !4   !S;F]A+3(P,C(P-S(R
M7VQA8BYX;6S-G5UOX[@5AN\+]#^P[DT+C..)LRV0[&07&4^R,#:;I+%GMNVB
M6- 2XPB1R8"2$_O?EQ1%6:)X)"5%2<[%C$=\#_52?$Q27\>??MQM4O1">)8P
M>CXZ/OHX0H1&+$[H^GST=3&^6,SF\Q'*<DQCG#)*SD>4C7[\X8]_0.+/IS^-
MQ^@J(6E\AKZP:#RG#^Q[=(,WY S]1"CA.&?\>_0-IUNYA5TE*>%HQC;/*<F)
M*% [/D-_.SK^#J/Q>$"]WPB-&?]Z/Z_J?<SSY^QL,GE]?3VB[ 6_,OZ4'45L
M,ZS"18[S;5;5]G'WL?RCPC^E"7TZDW^M<$:0.%XT.]MER?E([K?<[>O)$>/K
MR?3CQ^/)/W^Y7D2/9(/'"97'+2(C'25KL<4=GYZ>3HI2+6TI=RN>ZGV<3+2=
MJF91FG3H:TZRY"PK[%VS".=%M_?N!H$*^;^QEHWEIO'Q='QR?+3+XI$^^,41
MY"PE]^0!%<T\R_?/ J4LD22,RFV/G#S8S:2<3V3\A)(USDDL=W0J=W3\=[FC
M/Y>;K_&*I",DE8(/L%VGC;K*H(EKLW>$)RR^I.]S;49[LB^^.SS_'QI0CW?>
MA"7+<?HN\_5(Y[9OR/N.^"'._9$6XSQYWY&N1?Y?;.=MRV\^O/;CFLJ-U^)3
MPR+9Y6("([$V*:OH&(&+/1030UEW53N+&O6F<C1GO-UV.3,6=68D.EJSETE,
M$E'W="H_C.6'HMGB/[_/F%@)7*RRG.,HUS45S3@?6<HGIB6IO.#:%^913^-*
MQ21B8FIZSL>I.HPJ_(&SC76W9:N9I?#W=%7%J\,B=@$8;<@XR=B61^1-O5)W
M"QVETM$F%0JYI")T_'4Q^J'0H-^TZC^?)H=:''2T6 )M-X3F2U&CI07-8E?=
M;#.E>[E>%D0G6PR9?:PE2&H<=_"%V'$L=WZ5XK7%OE'NJHNMMG0?-PJ#Z&2;
M([.7*PV2(E_=_(5D$4^>Y7*^JQT-F?-.MYAL]7U-$Q8";6,P"36MIX']GJP3
M.;5("_+\ELB-'<,8H'<]]'?:-N<"JS@(:(8X!&>+>A"JHCQQ=$'I%J?WY)GQ
M+GR:,M?4V$R:L-0U03%B,0:BH;1(B3T1\8^M.&,G/-WW0M%2NN8"L&JB8<B"
MHL/N#02DDOME9,DQS1(Y@/5"TI8Z/]T S+9./0Q=4)P YN!3DDKOEY3%(TE3
M>3\ T_X!Q29V30MLV.2EK0R*&- >R$P1@<J0<+"Y?)&K<[%,&MC8FMXG/"W;
M7?Q4XF 1,AT.I*@(0S+.$TFUVQ ]#+64KND!K)K<&+*@B+%[ UE1<E3H_4-R
M2>-!B%0Z/X 8-NUXE*( X6@ZZT-#J'V"<95D$4Z5ERNQ+>MHGD7K&A#0K@E)
M2Q@4*) [$!85H)DI0KP"\R^"^3!<:DH_L+2LVE&I9 &"8GKKPT3JO4 RVW+>
M< W/.+#4V4W9'K/5_5E %P0H/>9:=VV5O &*IQGHDN9)OI?/T]UL-RO"+8UK
M2URQ 9G33)CE0;  F#(94#(D=4@)O?2\ODM <_D0(]@<4^:6 +O))@5-34 D
M6(T!-!RTQ3.E7HB8B9&)XW1.8[+[F>S!=K5T;ID ;#:A,$0!46%W!F!1BE&A
M1D+N!8P[GFPPWR^2J&>J: O=H@$9;;)AJ@*" [ &T%&JT6(^\SF3+/%N'@M0
MDX=$/0_>0PFH=PM+C^TF,X X('2Z'0($B2#4C/()TIQ&C#^SVN,.,[85 ^!^
MQF)XA=(3Y1:J04UHHM49$A!@0WP"F#5"/ZAG4A"3[_$4%2!9@Q?B+N)8'*BL
M_.<ZH>08;+]5ZY:N#KM-IBS"@$B"W0'\E,H/^@.2,>B6A@+-] U-G?J'9CH4
MFFG0T$S? \WRE04"S<D;FGKB'YJ3H="<! W-R;N@$1WO=:R9B8^W?,E>;0]G
M@THOR+2M6H$YR,+#I>6M#Q89(-<S,L0G)L7"ZI;?<?:2T A>,D-R+\  IJW4
M&-KPT+$;[..G6A#K.*]CC5J4]WY)M,S/*-,T:1]BE"8\2)K&>@<7I?:)Q!W+
M<IS^.WGN/!&WB[W@835LA:2A# \5F[T^8%0,$D$^3JQ+7.4-#>NK9$:YNU>
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M^+#WY"&A'C =$UYX-+#'=!AWA3D4.4K.62L3%?N_E"@P]"UC*'*4-+1&8L/
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M4^B9M2M<S\)4TS5^<C$OIB2NH$#B%]"UIF^J^J(T^9G<>I/10<8O'W 4-\5
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MYT">A04T/:=J]*XP$P%U:@U2G;>$H-B[6[2A#4WRKN9\#=4LH>+!&2PA(:T
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MR$0$<!QVY8WI2%<L5YP0*E^=U[R 97WAH;[<7'G4($_T09 VAFF3<I@,2#"
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M1/#:ZI(1OQ8U\OF[54/F+5F47\5Y7HG'G1>U11B8<66$\"2+8+ AJX;=.!.
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M($- 8/;SU51^@N'"3,DX=W'!W9A]&N3M>Y(&Z1VHT)T!@\S6'"<T2E8+_LO
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M7AX<-^/ ]N9)3\-*0L!0MB\LK<3,8;^ (/;ZAQ(<6P@0M!]O=)@'-R;,PE+
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M1ZJ9-*A'@&S@'/7MZR.\V[*0RETX_GR_N)[;=$P1B7O##3KR[>YP0SJ=XZG
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M,+ZZ!7(#T?S!90WP'?==8@?KM#,%MJECE&P9XBVV84&X5JFD1Y"]WQJBR][
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M*&037,QK3H#BGD4HN6\37\RGU6M(O./B09?FLHC0DQ:HF"\:VX>,_?$RB,W
M6*R9'(@>M>^.=5EPN2%<^]+K/%\0&;<"#=+:SDNV:XFV^_G0[5X^-PIXY"A
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MJ7O<8FJ)+R"WHFZ=QO0GT&VD*M-_K9_.0;4%1+:J2F%,8Y=L\#MP1*=JNV8
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MVC_BW9W<M$5C22TFB2G-KJA6)@'Q&*4_HB8BI-YK0(!%UP:__6=!]_0%O;C
M=$"=ISB.BA_/RN3YTLA/6U#>[LZKK#3\9_)T7IB9_;XZ2Y[/9O2N1@B:9C+-
MFF:=U"N9;4[#Z0]IL"6]C^1(6?"'M+1I4TPP8U/6%_2&LDQHLO@=S64A/Z-5
MYH7,I#7=[LZL;KIY,J=[4U0?Y<@^+6)Q1[J[0SSJHBA+' J=0S:=&GJ_;J$0
M2KN:SD,^19O-'XWM]GOF+I_@WO[Z_'=Z&S;XQ^<O3V2+"[J"4U!MKO<!5P7[
M3F1HSFKL];(QBZ)5(L=7BU6WHBLTK<]-E56=?+%L:GE*?[_,&KX$0LAREHV9
MFD+/K%WA7A6FFJ[QDXMY,9V3I"0!B%] 5DS?5/5%:?(SN?(FHX.,7SY@)VZ*
MGA'@;: 62"RPB5E=TEULO_^L98L;Y>@@@6P/)#-MP#/F29#PG[<$W4K/1P='
M6/J+NBVL/G20/&?F2JJ%N^_M:O('Z3U@&*"+F-DF(:\=(2;03,L\/Y!$PEYZ
M5#8J?W9WKBR DDOE#^;*@[ZFM>%UP:'O91 VLZ)B52OYX?3Q*^AZM 0R9DX?
M[Q_L[KR.IIO7>C/YGCD^*I>$UMCCH^E6J67>$H=H6]+]_)86>#[4*:%CTH;X
M*;1SDH;$?V;$%?ZU,BVID1"0+0UN&MG1+%F8Q826KK?^29TU.?[QC#2&:5<W
MCMD\W:PS\X\B%;]NB,]@%?1KV5K:V5Q?B3=F%>T*?546I-R.#8&CJ(BGY+(%
MS L72U.U-T!MO>32W<6E"Q@,,9N&J%2T^3]!FCTA+V2A)/#N2M[NSE^[9$RE
M_=FDI'5T<RA\9;$H.B]HHH]9*PE__/>F!;VUNSLU?=Y835$94;"N=//+LA5]
MV!3=>H0*[?M'KD4*==FIHR4+<SFA,U/1DFF#5[3T\Z+EX87V[:K ZYJZM"-.
M5BT=7BO;1K<B*\:O';Z>9^>J@T5+'E..^0KZ2RW'#EO@K,*E8VM K&'Z$3$'
M.E[LT/@6)TN5 B"1/V,#J(G.Y#%<VRA5)/1CVM:%*/4S6?8V:X"HGUAMW>19
M1=-RBRG-&4U%C^ <&Q-Q.[QJPR^7348_F>IXR[J$.C5^-CRZ80] ,B-%+>F(
M'3 I\G_G3;TZFUN31F\Q,>NK7^-DKZBFY2HGPAV[+@/9ZDZN$-4SZ9H,/Q:O
M 8F.:>M6E%I:61/?6B?3>5:=F>$R]@^2W^=%&=B)?Y(8DFVTD/;]%D(,C:$'
M.A*%M DM?4S"4"\Z'R,H:&R/_P*GW-V1D:NZ4W:I,GJ" 7GJN1>3#0DKNNXU
M6:[^>\@YN:@T/C&9%/.'+@#YAB\OYJ0LK_'K1?:'\J$+S(^T*MK'(FN*@& C
MEK:J2C -OA68'G:_"'6%;$D6P[FWYG6?CM^S$?\+\WAUW]&$>EPRJ=TK4[8R
MB%W2XJOLS#CUNL4H*3Y=S>@&LOQ+DY=_SQ;+1\]2>N/9JLQHV]>PK.A\"[ZV
M^.6_R&S")EH6:U6Z#^?S^M2LTJ.#>U H?JV3YTR(_CX\VMWYI:B*Q6K!0]$>
M+8B;6'_M%2[4N&8Q(8(G9K5/5^V\[@Q3<D=&;)&!TI67;Y#C3A2"W=!E(=HX
M$Y]F^Z:@7^J-5\' I[[I9592C%" J -[!<V1KE\.15,NZ1_U9*!%6Q.%Q27=
MV*(B$=*)[\,JM?BP+L^%@&'GZ.VF&TCVO3Q,4Z=/U<S!A;%W-F0J?9Y"+(@X
M?)DU]'4.%27E]X8.;-RHB,/(OVB^U=6XRQ@+3A9$4E!Q9J2+=(Z3[.X0V[QH
M1'L:^@A%BH=NC5H4(!V#F$' <XDPP743SV2)<9WS5D54Q6)(=ATOI1E4=76'
MS0%:,#U! F.YFI D*]=W(.2P/OIQ4X3:(-T,O)HHAVB\$Z883.;AWF0?L[D1
MEL7M*.\^BGO__[ES)_FQ,&7^??*"9-(C>@D9S\1I:*SDSAV-G?[P[/2?<=Q2
M0HT/1T*-]!F]__7QDY]/DJ<G/__\XOC9L]-?__$?7QU^Q?]^]>+XJ?VWOG)"
MJJAIW!N>E-GT37)$TV])8\L?)?K]E*YWMFQI:O:O1Z0:YMT<^W+XMT<)]NA.
M6_S;R$9A&B_M&.>FX0B9W0J:?[PWI9GQ+Y[97^BK[]W[FS^5U\_&GKC_MPV1
MFF!W[;X^2EZOES3!XR:;%--'R:_9PLC>D\RB#3\*?_2U_16^V33ZO=[H37$V
M[^(I?_WZ)?X'9T+_I<,<.==)8[(W=R8&#.U[4E5 #%<[ZV%(>]F%A!R-&*X.
MJQ8B^[SOTR95Y+ZJ(D\:ZVM^"D6-=#Q6.?I.-/6?D>I/2J2!'WQHV[-D_IX5
M#N'S_&,UEW-3TGN:M9,_/@([&3@8A^%1,5K[&L?@EY>I(%C&JH(-YF4=K&X2
M7RM2D+)D8K<C=>+\HF@E/->0Q5\9-8K$.Q@9%CY03#]E@XX-(_;V]^99P.$'
ME7L=#S.I:7:/1"'JN?;)8B+MJ*AX\;(EE]FA-.D96Q.D\(6_E V&?(9X;DS7
M[L<KH3UN1:$156;3&K!];-.7:SF@J=+0BC7,F7I8\Z*=EG5K1FCFD54 !PO6
MU_..2#A]'2V(-:QP$9BNZF@T&7<6>X$6%A/>OK@7-B_[ ZD@'Y,-/."X A(@
M0 $O_-T*N,"2C+YIL20:6MH'AQ<L"$2J\3'P:7H/EGNA"6XNC%9:$JF+#;V%
MR*>LIYQP@;#=[W6=MUT]?9,F_S UK3:#R0.C2,SND3F&H=$>6V#?"DUPP4;Y
MT$FT(C/91OZR@$]=(8_C$1DR%Z0\D_D=#W=1-V^(?R[($(/QU=+RX ("3V)V
M<)X1Y<(REP0 Y;.))@J,;"/IVIOWT<8:BF8TAZ#OY0M-JWB)"$*+AQ66?D-3
M_XLS8\8:^$WYE-5Q%\92L6?.1ZH)"</IZ4&ZI>($P:=+/E4ZK_!8BTKC8JNF
M91)16;+1G;W%<OWB?!</F5,$PO>E.2_,A?()B8QL]4X\#<)&ZN'HS%C("8%Z
M#GZ0BFU8>!!WY\^9&!L>=\PQ[B>WNV-8V>@N3$E4LG=T=Y\N>]7-6Z(6VH *
MDU5SWR6+)<@5DYNQ8:X\?FX@^XO*#-21LSHKQ24'7UG=P-4^HX=9Q5B5&DT9
MNO8WK%?\X1T\I5,VWCUGG=#QZ!+4/=^^_RR/#V4 WN4X_Y",K"\LC'CB*7;*
MQH]I_%,W;$H'R);*Z(D+;[%/:NR;3F2V*MEKJ?Y,C2BLZ('2T7DA[EE^#WP?
M3;O*Q,,4>#0>''S+#HU^YJ$,>48RJ DCSI>)5Z_#*HD(C44+D[S'&T(/]Y@>
MPBMYP],][DFZQY.,I-2KC*3N6DC_V,<?8A(6"^LJ+-@;:QK8RUSP)M &D@F&
M;GEH*^<;S0_XOW<?'*:'AX=$[D1U:Y.1IA,DGI#<)Q.*?KTW(6L$&GQNY)/]
M*/HQ2%V(%QNFZXX)YN!Q&QR"TI05&R.(8XJH*C78A:;&;K@HXY808IK(RA(.
M^LPXHP/Z*I1#LC%8S)0?RG;X..3)B1''507]^$E=K30]XD>XR=E^GI$0H^]
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MGKFS8K)D5KQ%W;9/$.#0$/TN%*$H4FX=U6MNB0]-NWQ .,$'L:@;P:B_>OS
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M4+X=@5(%[EL:%C7TLT*#'W*LV=50"4JE^Q:)P[WWBK(("G?J8H#KV+XK(4
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M37MV02]N[1Y%SNF#]\T(/K$8].UP'SB@__ VH/\1 OH/;P/ZG\4-N[I-P'@
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M\N</,V%&??KPJ/5]T@\XX^?]^O2?'J=)Z*,7S]Z5G/0C/O9DFXO=+>=*+O;
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MS;8';\L\Q;YEDI59T(2X("Y"1R]%BWL%*XS[MOTM[PM?@/%RX +H- 5Q5Q+
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MI1$^+QL5P[R00,1+:IP+:D##O4.$N&X9ZJZ)F^K%:@)S;C'<P!8Q!;76!DU
MX=U#P>4$&\R6*4OL?DPN]5?(]39E5HSL./S#.GNT6G_KFF) '+>H=&15(].=
M,'>OZD0D'BB->0*KT#BB!H".H$X@\U2=G<1%UJ ZI[ 9/GX*8#222Z9-"!7*
ML2R ,<8IZ=*^1-'TQ<\0UNL$&YY$^XT:;N[4GK6^PR%Q$I9=\-AQB/8F,Y0S
M9BB_T$URV#>CW 0!6Q(7'*5UX'L+_IEDS4H3$A38#_%&]]T^@V4PRA"0[(%O
M(FF M@]"R&3L:4@_/G=U>C!2ZKD.-<.0/TWJ;C[."V[$H=ZL4:X4S[UW&\_]
M&/'<>[?QW,_N1FU@^7/!SV)0$>'UOZKEREFK65&N6$8W-N&W)-ZO.7G6PR2^
M)O8F$;MMIL@E<FYYP,^1-K!.+>X##(OBO"C-F1EOLRYZA(UX2E0PDXP\%=0
MI+/.238=22"(C&&VGI5^'FI<7CX5DC#JY73N=QC<BOH1OJ]32!AV]5_U_6D2
M3UE7=.7IC54=2S065X\EL??HA'MFC?4_.81LA!N(R*.V;W;ZGK$M37=WM-E1
MH5X9AY#.SJ4V$9!W6YPL5(.82-,%ZBT79AL--LA8-T(^;[B!Q;[D4I,@<6C:
MJ 0@K>7&YD0^9.Z+I<.TDNY^0#5:6S1;NEB2>,#)?;&UM!5W>:]7:C+6@I?4
MR<(#TXPG<>RGPO#>.7UC&*$4D]2Y=T>\ZB,]T>BAB9'<3NG!B^B+@4XMS8X
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M<9S<.SSZ]COYXH,31$01SFJ\ ?3PI%D1&W@]KYNJJRO97;6 E!N ]<W E\>
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MQ,[&;BX&<.]/9>5;EZK=EU$."8/"MW"A?Q!Q"$$(4@M-:F'Y>,!CTM$FSKK
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M+0>X=V.>]!KCP1FG6 !%*TC4Z&:S+U*[:#<!$3OWPRC2..L(<6<=QOA= 4-
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MBVWK(-M*+PX6N#PJC4Y8>1ETJ-WNHAX_I$4O7LN0E%_8+7OR)V_9%%ESII(
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MR<_(][OUNG\$K_MW']3K_AZ16WM$_/63Y\_^"[+SZY]>__+SX_\/4$L#!!0
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M!N!  .!0N>$0<"F5/<<=HR@7V5^\?) (:E$'>E)%P<E$R&PS!3(E@KAL_?C
MHP'.SIX=;'7L G^2RA#"2"=>6U);4_)4'G^N\QOFS*[,9[?@*HXX6V-@L<)$
MJUEC5">.!ZIZW><.6*4=GLJ6'-5JO0R-V.8:N;OC#4$O@T6)KDSE.-P"192D
M%$>+FNA/A++E8#(,C$\IF@:VV<5S_<"%[I@:UH/GS(3>4>*"H!E8CYK;-&Y[
M F0RP.0"\E#,_"GM%JANK,=8^&EZ;(J7T>,?.B5<R]VR#NMQU"4U*"KN#9S
MO/=SD8%((2I Z"/31,P%?X/"Q:?H=F8W.$ #IB-5Q&'N%/-5L]OT KWH>NB@
M\=Z\=03W@-(0/3444NMC2*MKHN*A_J@D%6A+?=(W-52P;":5E2,.?^04,1C1
MFN<XV+)_ZPNH)VY0)J7D>Q)T8'[2U&\;^A%F_+<8^2.P(/V^YX!I&9C,X4X9
MY8K7PFP,MT[0/LDY)AK%B^"D-4P_5_)N\0# YM%*@/Z)//#MNHR1(+D?'[R
M;Y8^:N[["%Y884B=_R.[G]LK9C(2&(2Q &KM']EB9B\3O SYY]]"51^AD9&,
MA9HHSV99ZM\1T5=ACJ*.&T2LF'^QE2L'*((.#OR>CKB2"U<H'RU<@)0#E%<
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MA33FCAFSPQD0^3RR"\>0S412BZ >5-G1SR#JW I1+\LIMV4Y+:[RKA;5=QT
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MM=*]6D$4WS4^O'D3C-?NSO\#4$L! A0#%     @ E(/V5*H\<X$J P  MPL
M !$              ( !     '-N;V$M,C R,C W,C(N>'-D4$L! A0#%
M  @ E(/V5'*4Y-[^"@  @(8  !4              ( !60,  '-N;V$M,C R
M,C W,C)?;&%B+GAM;%!+ 0(4 Q0    ( )2#]E0CQ;DJ60<  -U7   5
M          "  8H.  !S;F]A+3(P,C(P-S(R7W!R92YX;6Q02P$"% ,4
M" "4@_94^;L\E!5D   /(0( #P              @ $6%@  <VYO85]E>#$P
M,#$N:'1M4$L! A0#%     @ E(/V5$KFB6XI9P  WTX"  \
M ( !6'H  '-N;V%?97@Q,# R+FAT;5!+ 0(4 Q0    ( )2#]E2- $J[,!@
M ,N"   ,              "  :[A  !S;F]A7VDX:RYH=&U02P4&      8
,!@!Y 0  "/H

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
